{"study_id": 92280, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to develop a method for identifying step-by-step kinematic parameters in Parkinson's disease (PD) patients and healthy controls using a short 5-meter gait assessment with a body-fixed sensor.", "results_summary": "The study found that the proposed method could reasonably distinguish PD-associated gait from healthy controls, with a discriminant model achieving 89.5% correct classification, 95.8% sensitivity, and 78.6% specificity. The results suggest short gait assessments may be clinically useful for PD detection.", "population_specificity": "14 healthy controls and 28 patients with early-to-moderate idiopathic Parkinson's disease.", "effective_dosage": "Not applicable (gait assessment, not a supplement).", "study_duration": "Not specified (single assessment).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:49:04.685311+00:00"}
{"study_id": 92281, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the effects of standard endurance and strength training (SET) versus medical Qigong (QG) on psychological functioning, quality of life, symptoms, and physical functioning, including walking distance, in patients with advanced cancer.", "results_summary": "SET was more effective than QG in improving perceived strength and walking distance, with a significant impact on exercise capacity. However, the order of interventions influenced outcomes, with reduced benefits when SET was administered second.", "population_specificity": "Patients with advanced non-small cell lung cancer (NSCLC) and gastrointestinal (GI) cancers receiving or eligible for chemotherapy.", "effective_dosage": "Supervised SET twice-weekly (specific walking dosage not detailed).", "study_duration": "6 weeks per intervention.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:49:05.161610+00:00"}
{"study_id": 92282, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness and safety of oscillatory whole-body vibration (WBV) in improving exercise capacity and quality of life in patients with pulmonary arterial hypertension (PAH) on stable therapy.", "results_summary": "WBV significantly improved 6-minute walking distance, cardiopulmonary exercise testing variables, muscle power, and health-related quality of life compared to the control group. The intervention showed a net benefit of 39.7 meters in walking distance and substantial improvements in other physical performance metrics.", "population_specificity": "Patients with PAH (WHO-Functional Class II or III) on stable PAH therapy for \u22653 months.", "effective_dosage": "16 sessions of 1-hour duration within 4 weeks.", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:49:06.190437+00:00"}
{"study_id": 92284, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the feasibility and cultural considerations of a minimally supervised, home-based exercise program incorporating walking for individuals with Parkinson's disease in Jordan.", "results_summary": "The intervention showed a high retention rate (86.7%) and adherence rate (77%), with improved UPDRS-III scores in the intervention group. Sociocultural barriers specific to Arabic culture were identified as potential challenges for program uptake.", "population_specificity": "Individuals with Parkinson's disease in Jordan.", "effective_dosage": "Not specified (home use of an exercise DVD, walking program, initial instructional sessions, and weekly phone calls by a physiotherapist).", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:49:07.289075+00:00"}
{"study_id": 92283, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effectiveness of exercise training, including walking, in improving exercise tolerance and health-related quality of life in patients with very severe COPD.", "results_summary": "The study found that exercise training, including walking, significantly improved 6-minute walking test performance and health-related quality of life in patients with very severe COPD, with weighted mean differences of 67.1 meters and -8.041 points on the SGRQ, respectively.", "population_specificity": "Patients with very severe COPD (forced expiratory volume in the first second <35% of predicted normal value).", "effective_dosage": "1 to 5 sessions per week, lasting 15 to 40 minutes each.", "study_duration": "4 to 52 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:49:07.686119+00:00"}
{"study_id": 92285, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the safety and efficacy of autologous cell therapy for intractable peripheral arterial disease/critical limb ischemia, focusing on outcomes like amputation risk, wound healing, and survival.", "results_summary": "The meta-analysis found that cell therapy reduced amputation risk by 37%, improved amputation-free survival by 18%, and enhanced wound healing by 59%, with no significant impact on mortality. However, efficacy was not significant in placebo-controlled trials or those with low bias risk.", "population_specificity": "Patients with intractable peripheral arterial disease/critical limb ischemia, particularly those ineligible for revascularization procedures.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:49:09.195974+00:00"}
{"study_id": 92286, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether effective antiretroviral therapy (ART) prevents developmental milestone delays, including walking, in HIV-infected infants compared to HIV-unexposed uninfected (HUU) infants.", "results_summary": "HIV-infected infants on ART showed significant delays in walking milestones (both with and without support) compared to HUU infants, with greater delays observed in those lacking viral suppression and immune recovery.", "population_specificity": "HIV-infected infants (initiated ART by age <5 months) and HIV-unexposed uninfected (HUU) infants.", "effective_dosage": "Not specified", "study_duration": "Follow-up duration not explicitly stated, but comparisons were made at 6 months post-ART.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:49:09.869955+00:00"}
{"study_id": 92288, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to identify gait deviations associated with plantar heel pain by reviewing quantitative gait variables in affected individuals.", "results_summary": "The study found strong evidence that stance phase duration remains unchanged in individuals with plantar heel pain, but identified compensatory changes such as decreased rearfoot center of pressure duration and increased midfoot/forefoot contact time and impulse. Limited evidence also suggested increased medial forefoot and rearfoot mobility.", "population_specificity": "Individuals with plantar heel pain compared to asymptomatic cases or limbs.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:49:11.999875+00:00"}
{"study_id": 92287, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to examine the effects of a functional training program, including walking, on physical functioning in hip fracture patients during short-term stays in primary health care.", "results_summary": "The study protocol outlines a functional training program to improve physical functioning, measured by the Short Physical Performance Battery (SPPB) and secondary outcomes like Timed \"Up & Go\" (TUG) and self-reported measures, but results are not yet provided in the abstract.", "population_specificity": "Patients aged 65 or above who sustained a hip fracture, excluding those with severe cognitive impairment (MMS-E <15), inability to walk 10m pre-fracture, or terminal illness.", "effective_dosage": "Not specified", "study_duration": "During short-term stays at nursing homes post-hospital discharge (exact duration not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:49:13.168200+00:00"}
{"study_id": 92290, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 45, "study_goal": "The researchers aimed to review available information on idiopathic toe walking (ITW), including its prevalence, classification, and therapeutic approaches, and to differentiate ITW from tiptoe walking with neurological or muscle deficiencies.", "results_summary": "The review found limited research on ITW's etiology, prevalence, classification, and evaluation but consolidated existing information on these aspects and its treatment.", "population_specificity": "Individuals with idiopathic toe walking (ITW) and tiptoe walkers with neurological or muscle deficiencies.", "effective_dosage": "Not available", "study_duration": "Not applicable (review study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:49:13.908515+00:00"}
{"study_id": 92289, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the effects of three locomotor training methods (G-EO, Lokomat, and PBWSTT) on gait velocity and spatiotemporal symmetry in individuals with chronic traumatic brain injury.", "results_summary": "All three training methods significantly improved self-selected walking velocity, with Lokomat and PBWSTT also improving maximal velocity. The 6-Minute Walk Test improved for G-EO and PBWSTT groups, while the Lokomat group showed improvement in mobility domain scores. No significant changes in gait symmetry were observed.", "population_specificity": "22 individuals with chronic traumatic brain injury (\u226512 months post-injury) and hemiparetic gait, able to walk unassisted at 0.2-0.6 m/s.", "effective_dosage": "18 sessions of 45-minute locomotor training.", "study_duration": "Not specified (total sessions: 18).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:49:14.383245+00:00"}
{"study_id": 92291, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "To evaluate the efficacy of functional electrical stimulation (FES) for improving gait speed in people with multiple sclerosis (pwMS) during short and long walking tests.", "results_summary": "FES showed a significant initial and ongoing orthotic effect on gait speed in short walking tests, with mean increases of 0.05 m/s and 0.08 m/s, respectively. No effects were observed in long walking tests or for therapeutic effects in either test type.", "population_specificity": "People with multiple sclerosis (pwMS) experiencing foot drop.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:49:16.103573+00:00"}
{"study_id": 92293, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to describe brain MRI findings in individuals with dystroglycanopathies (DGs) and relate these findings to functional outcomes, including motor function and walking ability.", "results_summary": "The study found that 85% of the cohort achieved independent walking, but only 33% did so in the group with the most severe brain malformations (group 1). Walking ability correlated with the severity of brain imaging abnormalities.", "population_specificity": "Individuals with dystroglycanopathies (DGs) enrolled in a natural history study.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:49:18.578968+00:00"}
{"study_id": 92294, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness of a community-based lifestyle intervention, including walking, in increasing physical activity and improving dietary behaviors among Vietnamese adults with metabolic syndrome.", "results_summary": "The intervention significantly increased moderate intensity activity, walking, and total physical activity while reducing sitting time. Dietary improvements included reduced intake of animal internal organs and cooking oil usage.", "population_specificity": "Vietnamese adults aged 50-65 years with metabolic syndrome from Hanam province.", "effective_dosage": "Not specified (walking group participation included in the intervention).", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:49:20.762664+00:00"}
{"study_id": 92298, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were attempting to determine the relationship between resveratrol and breast cancer, focusing on its potential protective or harmful effects.", "results_summary": "The abstract discusses conflicting evidence regarding resveratrol's effects on breast cancer, highlighting variability in dosage, administration, bioavailability, and molecular traits of breast cancer subtypes. No clear conclusion is provided.", "population_specificity": "Not specified (abstract focuses on in vitro and in vivo breast cancer models).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:49:22.651964+00:00"}
{"study_id": 92295, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to test the effectiveness of a telephone-delivered, pedometer-mediated walking intervention for improving pain outcomes and increasing walking among African American patients with chronic musculoskeletal pain.", "results_summary": "The study found that the walking intervention improved chronic pain-related physical functioning, as measured by the Roland and Morris Disability Questionnaire, and also examined its effects on pain intensity, emotional functioning, and overall improvement. Secondary outcomes included potential reductions in healthcare utilization and opioid use.", "population_specificity": "African American patients with chronic hip, back, or knee pain.", "effective_dosage": "6 telephone counseling sessions over 8-10 weeks, with pedometer use.", "study_duration": "8-10 weeks (intervention), with follow-up assessments at 3 and 6 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:49:22.671605+00:00"}
{"study_id": 92297, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to examine the long-term patterns, determinants, and effects of exercise interventions, including walking, on physical activity behavior in breast cancer survivors.", "results_summary": "Walking was maintained over time among breast cancer survivors, unlike cycling, which saw a decline. The exercise intervention helped sustain physical activity during therapy but did not prevent long-term inactivity in many survivors.", "population_specificity": "Breast cancer survivors undergoing adjuvant chemo- or radiotherapy.", "effective_dosage": "Not specified for walking.", "study_duration": "Assessed before, during, and up to 12 months post-intervention.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:49:23.072316+00:00"}
{"study_id": 92296, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of traditional and CAD/CAM prosthetic sockets on clinical characteristics and quality of life in patients with transtibial amputation.", "results_summary": "CAD/CAM prosthetic sockets significantly improved walking time, distance, pain-free walking time, prosthesis application time, and adaptation time compared to traditional sockets. Quality of life measures, except emotional role limitation, were also significantly better with CAD/CAM sockets.", "population_specificity": "72 patients with transtibial amputation (36 using CAD/CAM sockets, 36 using traditional sockets).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:49:23.182677+00:00"}
{"study_id": 92299, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the efficacy of abobotulinumtoxinA + standard of care versus placebo + standard of care in helping children with cerebral palsy achieve functional gait improvement goals.", "results_summary": "Both doses of abobotulinumtoxinA (10 and 15 U/kg/leg) significantly improved Goal Attainment Scaling T scores compared to placebo at weeks 4 and 12, with notable improvements in walking pattern, falling, tripping, and endurance.", "population_specificity": "Pediatric patients with dynamic equinus due to cerebral palsy.", "effective_dosage": "10 U/kg/leg and 15 U/kg/leg (single injection).", "study_duration": "Follow-up at weeks 4 and 12.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:49:24.158546+00:00"}
{"study_id": 92300, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the impact of a web-based lifestyle intervention, including walking, on physical activity, dietary intake, and quality of life in individuals with metabolic syndrome.", "results_summary": "The intervention group showed significant increases in walking activity (505.2\u00b1505.3 MET-min/week) compared to the control group (321\u00b1884 MET-min/week), indicating improved physical activity levels. The study also noted improvements in general health and vitality related to quality of life.", "population_specificity": "Adults with metabolic syndrome in Tehran, Iran.", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:49:25.986586+00:00"}
{"study_id": 92292, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the accuracy and feasibility of different physical activity assessment tools (pedometer, IPAQ, and ActiGraph) for measuring walking and other physical activity dimensions in patients with Bronchiectasis.", "results_summary": "The study found that ActiGraph and pedometer showed very good agreement for step counts (97%), but ActiGraph provided more precise measurements of physical activity intensity and time spent walking. IPAQ was less accurate, overestimating moderate-vigorous physical activity and underestimating sedentary time compared to ActiGraph.", "population_specificity": "Patients with Bronchiectasis (55 participants, 22 male).", "effective_dosage": "Not applicable (assessment tools, not an intervention).", "study_duration": "7 consecutive days of monitoring.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:49:27.950589+00:00"}
{"study_id": 92301, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the impact of a supervised community-based exercise program on balance, balance confidence, and gait in individuals with lower limb amputation.", "results_summary": "The study found statistically significant improvements across six clinical outcome measures, with moderate effect sizes for balance and walking ability. Participants experienced clinically meaningful improvements in balance, balance confidence, and walking ability.", "population_specificity": "Individuals with lower limb amputation (mean age: 50.8 years).", "effective_dosage": "Biweekly supervised exercise sessions.", "study_duration": "6 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:49:28.123817+00:00"}
{"study_id": 92303, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the participation, fidelity, satisfaction, and reasons for completion/non-completion of the VPAN program, which included walking groups as a strategy to improve physical activity and nutrition in adults with Metabolic Syndrome.", "results_summary": "Most participants found the program resources and strategies useful, reporting increased physical activity and improved diet. Education sessions were the most preferred strategy, with high attendance, while work commitments and busy schedules were the main reasons for withdrawal.", "population_specificity": "Adults aged 50-65 years with Metabolic Syndrome in Vietnam.", "effective_dosage": "Not specified", "study_duration": "Six months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:49:29.643919+00:00"}
{"study_id": 92304, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether financial incentives, donations to charity, or a combination of both could increase older adults' initial uptake and retention of increased walking levels.", "results_summary": "All intervention groups showed higher adherence to walking goals during the 16-week intervention compared to controls, but no significant difference was observed during the 4-week follow-up period.", "population_specificity": "Ninety-four adults aged \u226565 years from Philadelphia-area retirement communities.", "effective_dosage": "Participants aimed for a 50% increase in daily steps, monitored via digital pedometers.", "study_duration": "16-week intervention, followed by a 4-week follow-up.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:49:30.509961+00:00"}
{"study_id": 92302, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess whether a physical activity program, including walking, combined with nutritional assessment, could prevent frailty progression in pre-frail older adults.", "results_summary": "The intervention group showed a lower progression to frailty (4.9% vs. 15.3% in controls) and increased outdoor walking hours (0.97 vs. 0.73 hours/day), but no significant improvements in muscle strength or gait speed were observed.", "population_specificity": "Community-dwelling pre-frail older adults (\u226570 years) consulting in primary care.", "effective_dosage": "Not specified (physical activity program included aerobic exercise and mixed strengthening, balance, and coordination exercises).", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:49:30.727633+00:00"}
{"study_id": 92305, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine whether implicit descriptive social norms (e.g., photos and text of active peers) could influence behavioral intention and participation in organized physical activity (e.g., walking) among inactive older adults in residential care.", "results_summary": "The study found that exposure to implicit descriptive norms of active peers was associated with increased implicit intention to participate in physical activity and higher self-reported participation (80% vs. 22% in the control group) at 3-month follow-up. No significant effects were observed on explicit intention.", "population_specificity": "Older adults (mean age 87, range 80-95) living in a residential care setting, 53% male.", "effective_dosage": "Not specified", "study_duration": "3 months follow-up", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:49:31.404780+00:00"}
{"study_id": 92306, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to examine the relationship between walking and sundown syndrome in people with Alzheimer disease, and assess how walking duration and accompanying walker influenced sleep quality and sundown syndrome.", "results_summary": "The study found that sundown syndrome was significantly correlated with sleep quality, and that advanced dementia, poor sleep quality, and shorter weekly walking duration were influencing factors. Walking with relatives and longer walking time improved sleep quality and alleviated sundown syndrome.", "population_specificity": "People with Alzheimer disease living in the community in southern Taiwan.", "effective_dosage": "Weekly duration of walking (specific hours not provided).", "study_duration": "Not specified (cross-sectional study).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:49:32.543221+00:00"}
{"study_id": 92307, "supplement_id": 1667, "safety_score": "80", "efficacy_score": 45, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the effectiveness of robotic-assisted gait training (RAGT) for children with gait disorders, focusing on modes of delivery and potential benefits.", "results_summary": "Most individual trials reported some positive benefits for RAGT in children with cerebral palsy, such as improved standing ability, walking speed, and distance, but a meta-analysis of two RCTs did not confirm these findings. The evidence was weak and inconsistent, with highly variable training schedules and minimal reported adverse events.", "population_specificity": "Children and adolescents with altered gait, primarily those with cerebral palsy.", "effective_dosage": "Training schedules were highly variable in duration and frequency (not specified).", "study_duration": "Variable (not specified).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:49:35.605545+00:00"}
{"study_id": 92309, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess the prevalence of depression in peripheral arterial disease patients, its independent association with the disease, and factors that could be targeted for intervention.", "results_summary": "Depression prevalence in peripheral arterial disease patients ranged from 3-48%, comparable to coronary artery disease rates. Depression negatively influenced walking ability and physical function independently of peripheral arterial disease.", "population_specificity": "Patients with peripheral arterial disease, particularly those who were female, African American, and had severe symptoms.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:49:36.004256+00:00"}
{"study_id": 92308, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of twelve weeks of physical-cognitive training on executive cognitive function and gait performance in older adults.", "results_summary": "The study found that integrating cognitive demands into physical training improved executive cognitive function and gait performance in older adults. The results suggest that combined physical-cognitive training may counteract age-related decline in physical and mental function.", "population_specificity": "Healthy, active older adults aged 72.30 \u00b1 5.84 years.", "effective_dosage": "Not specified", "study_duration": "Twelve weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:49:36.115100+00:00"}
{"study_id": 92310, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the neurohumoral and endothelial responses to blood pressure-lowering effects of heated water-based exercise, including walking, in patients with resistant hypertension.", "results_summary": "The study found that heated water-based exercise, including walking, significantly lowered blood pressure in resistant hypertension patients and reduced neurohumoral activation. The intervention group showed improvements in clinic and 24-hour BP measurements compared to the control group.", "population_specificity": "44 patients with true resistant hypertension (mean age 53.3\u00b10.9 years).", "effective_dosage": "1-hour sessions of callisthenic exercises and walking in a heated pool, three times weekly.", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:49:37.767780+00:00"}
{"study_id": 92311, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the effectiveness of a pedometer-based walking intervention, delivered either by post or with nurse support, in increasing physical activity levels among predominantly inactive adults.", "results_summary": "The study found that both postal and nurse-supported pedometer interventions significantly increased daily step counts (by ~10%) and time in moderate-to-vigorous physical activity (by ~33%) compared to usual care, with no significant difference between the two intervention methods.", "population_specificity": "Predominantly inactive adults aged 45-75 years without physical activity contraindications.", "effective_dosage": "Pedometer use with a 12-week walking program and physical activity diaries; nurse group also received three physical activity consultations.", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:49:39.012733+00:00"}
{"study_id": 92312, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the validity of sit-to-stand tests (STSs) in people with multiple sclerosis (PwMS) and their ability to predict falls and detect changes in balance and mobility.", "results_summary": "The study found that the 5 and 10 STSs were valid for assessing mobility in PwMS but did not effectively identify fallers or detect changes in balance. Correlations were strong with other mobility tests but not with falls or near-fall incidents.", "population_specificity": "People with multiple sclerosis (PwMS) with limited but retained walking ability (Expanded Disability Status Scale score \u22646.0).", "effective_dosage": "Not applicable (study focused on tests, not a walking intervention).", "study_duration": "7-week intervention with a 14-week follow-up for fall reporting.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:49:40.918676+00:00"}
{"study_id": 92314, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the effects of gait training with body weight support on a treadmill versus overground in individuals with chronic stroke.", "results_summary": "Both treadmill and overground training improved gait speed, endurance, functional independence, and lower limb recovery, but only the overground group improved step length symmetry ratio. Improvements were sustained at 6 weeks post-intervention.", "population_specificity": "Individuals with chronic stroke (>6 months post-stroke).", "effective_dosage": "3 times a week for 6 weeks.", "study_duration": "6 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:49:41.276136+00:00"}
{"study_id": 92313, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the effects of lower extremity power training and detraining on gait mechanics and velocity in healthy older adults.", "results_summary": "Power training increased fast gait velocity by 5.9%, with improvements linked to increased hip muscle function. Detraining further improved gait velocity (4.7%) while shifting reliance from hip to knee and ankle muscle function.", "population_specificity": "Healthy older adults (control group: 69.1\u00b14.4 years, n=14; training group: 72.9\u00b15.4 years, n=15).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:49:41.383020+00:00"}
{"study_id": 92315, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to identify risk factors, including pre-operative walking disability, associated with venous thromboembolism (VTE) after spine surgery.", "results_summary": "The study found that pre-operative walking disability significantly increased the risk of VTE (OR = 4.80, P < 0.00001), indicating a strong association between mobility impairment and post-surgical complications.", "population_specificity": "Patients undergoing spine surgery for degenerative diseases (34,597 patients, including 624 with VTE).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:49:43.803591+00:00"}
{"study_id": 92316, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine how walking speed affects foot kinematics in the frontal plane and whether this relationship changes with medially inclined insoles that increase pronation.", "results_summary": "Faster walking speeds increased foot eversion under normal conditions, but this effect reversed with medially inclined insoles, suggesting greater active control of foot motion to improve push-off efficiency. The study found no main effect of speed on average calcaneal position but noted a significant interaction between insole type and walking speed.", "population_specificity": "26 healthy young adults", "effective_dosage": "Not applicable", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:49:44.176542+00:00"}
{"study_id": 92317, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine the correlations between JOA scores and gait parameters in patients with cervical spondylotic myelopathy (CSM) and lumbar intervertebral disc herniation (LDH).", "results_summary": "The study found a significant correlation between JOA lumbar scores and gait speed in LDH patients, suggesting the JOA lumbar scoring system reflects gait impairment. However, the JOA cervical scoring system may need improvement for evaluating walking ability in CSM patients.", "population_specificity": "32 CSM and 30 LDH patients with gait dysfunction.", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:49:44.403881+00:00"}
{"study_id": 92318, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether a 7-day intensive preoperative pulmonary rehabilitation (PR) program, including inspiratory muscle training (IMT) and aerobic endurance training, improved physical and psychological outcomes in elderly lung cancer patients scheduled for lobectomy.", "results_summary": "The study found that the PR group showed significant improvements in 6-minute walking distance (6-MWD) and peak expiratory flow (PEF) compared to the control group. Additionally, the PR group had shorter postoperative and total hospital stays and a lower incidence of postoperative pulmonary complications (PPCs).", "population_specificity": "Elderly patients (aged \u226570 years) with lung cancer scheduled for lobectomy.", "effective_dosage": "Systematic and highly intensive preoperative PR training for 1 week (specific frequency not detailed).", "study_duration": "7 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:49:47.119584+00:00"}
{"study_id": 92319, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the efficacy of adaptability treadmill training, conventional treadmill training, and usual physical therapy in improving walking ability and reducing fear of falling and fall incidence in older adults rehabilitating from a fall-related hip fracture.", "results_summary": "All three interventions (adaptability treadmill training, conventional treadmill training, and usual physical therapy) resulted in similar improvements in walking ability, fear of falling, and fall incidence. However, adaptability treadmill training showed superiority in dual-task walking speed, while conventional treadmill training was better for the Functional Ambulation Category.", "population_specificity": "Older adults (mean age 83.3 \u00b1 6.7 years) rehabilitating from a fall-related hip fracture.", "effective_dosage": "Not specified", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:49:47.583398+00:00"}
{"study_id": 92320, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The study does not focus on Walking; it examines the clinical management of metastatic melanoma and associated complications.", "results_summary": "The study does not report findings related to Walking; it describes a patient's progression of metastatic melanoma and treatment with immunotherapy.", "population_specificity": "A 60-year-old former smoker with metastatic melanoma.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:49:48.963865+00:00"}
{"study_id": 92321, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review the effects of diet and exercise interventions, including walking, on lean mass and functional outcomes in older adults with sarcopenia or frailty.", "results_summary": "Exercise interventions, including walking, improved lower body muscle strength but had inconsistent effects on walking speed and grip strength. Combined diet and exercise interventions showed more consistent benefits.", "population_specificity": "Older adults with sarcopenia or frailty.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:49:49.772560+00:00"}
{"study_id": 92322, "supplement_id": 1667, "safety_score": "85", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the significance of backward walking as a form of interval march training for patients after abdominal aortic aneurysm surgery compared to forward walking and routine physiotherapy.", "results_summary": "Backward walking resulted in a statistically significant lower reduction of walking distance compared to the control group. Both backward and forward walking groups showed better mean speed post-operation than the control group, with no significant differences between the experimental groups in walking speed or heart rate.", "population_specificity": "Males aged 65-75 years with stable cardiologic status, absence of neurological disorders, and non-symptomatic abdominal aortic aneurysm.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:49:51.006515+00:00"}
{"study_id": 92325, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to examine how endpoints like 6-minute walking distance (6MWD) and functional class changes are associated with outcomes in patients with pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH).", "results_summary": "The study found that reductions in 6MWD, deterioration in WHO functional class, and delays in clinical worsening are meaningful endpoints associated with patient outcomes in PAH and CTEPH. These endpoints help compare interventions and therapies, with hospitalization being a key cost-related factor.", "population_specificity": "Patients with pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:49:53.165038+00:00"}
{"study_id": 92323, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the characteristics and prognosis of interstitial lung disease (ILD) associated with pulmonary hypertension (PH), focusing on exercise capacity (measured by 6-minute walking distance) and hemodynamic parameters.", "results_summary": "The study found that ILD patients with PH had severely impaired exercise capacity (335.0 \u00b1 190.9 m in the 6-minute walking test) and cardiac function compared to ILD patients without PH. Pulmonary vascular resistance (PVR) was the only significant prognostic factor associated with death in this group.", "population_specificity": "Predominantly Chinese patients with ILD-associated PH confirmed by right heart catheterization (mean age 60.0 \u00b1 12.2 years).", "effective_dosage": "Not specified", "study_duration": "Not specified (observational study with follow-up survival rates at 1, 3, and 5 years).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:49:53.433586+00:00"}
{"study_id": 92324, "supplement_id": 1667, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess the safety and efficacy of SpinalonTM (a combination of buspirone, levodopa, and carbidopa) in restoring locomotor capabilities in patients with motor-complete spinal cord injury (SCI).", "results_summary": "SpinalonTM showed no significant safety concerns at lower doses, with only mild nausea reported. Higher doses reached maximum tolerated dose due to adverse events like vomiting. EMG activity with locomotor-like characteristics was observed only in SpinalonTM-treated groups.", "population_specificity": "45 subjects with SCI classified as complete (AIS A) or motor-complete/sensory incomplete (AIS B) for at least 3 months.", "effective_dosage": "10-35 mg buspirone/100-350 mg levodopa/25-85 mg carbidopa (lower doses); 50 mg/500 mg/125 mg (higher doses).", "study_duration": "Single administration.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:49:54.679237+00:00"}
{"study_id": 92327, "supplement_id": 1667, "safety_score": "85", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effect of a 12-week walking program on knee pain in patients with severe knee osteoarthritis, as well as its secondary effects on cardiovascular health, function, and quality of life.", "results_summary": "The walking program did not reduce knee pain but showed cardiovascular benefits, including improved systolic blood pressure and walking speed. Adherent participants also had more daily steps, increased walking time, reduced waist circumference, but reported increased knee stiffness.", "population_specificity": "Patients with severe knee osteoarthritis and increased cardiovascular risk.", "effective_dosage": "70 minutes per week of at least moderate intensity.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:49:55.243237+00:00"}
{"study_id": 92326, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether preoperative physical activity interventions (PAIs) involving walking could increase and maintain post-operative physical activity levels in bariatric surgery patients.", "results_summary": "The study found that participants in the PAI group showed significantly greater increases in moderate-to-vigorous physical activity (MVPA) and steps per day compared to the standard care group, with these improvements maintained post-operatively. The effects were statistically significant at post-intervention and follow-up for steps, but only at post-intervention for MVPA.", "population_specificity": "Bariatric surgery patients (n=36, with 22 in PAI and 14 in standard care).", "effective_dosage": "Weekly counseling to increase walking exercise (specific step count or duration not detailed).", "study_duration": "6 weeks of preoperative intervention, with follow-up at 6 months post-operatively.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:49:56.206713+00:00"}
{"study_id": 92329, "supplement_id": 1667, "safety_score": "90", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to explore the experiences of adults with intellectual disabilities participating in a walking programme (Walk Well) and assess its impact on physical activity.", "results_summary": "Participants reported positive experiences with the programme, though not all showed significant increases in walking. Barriers included difficulties with self-monitoring and reliance on carers for support.", "population_specificity": "Adults with intellectual disabilities.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:49:56.617451+00:00"}
{"study_id": 92328, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to determine whether intensive physical therapy (PT) initiated within the first 2 weeks after a stroke could improve motor control recovery.", "results_summary": "The study found no significant difference in motor control improvement between intensive PT and standard PT, as measured by the Fugl-Meyer score. Secondary outcomes, including walking ability, balance, and autonomy, also showed no significant benefits from intensive PT.", "population_specificity": "Patients within 72 hours of their first hemispheric stroke, predominantly severe cases (NIHSS score \u22658 for 82%).", "effective_dosage": "Intensive PT included 45 minutes of additional exercises per day compared to standard PT (20 minutes/day).", "study_duration": "Intervention lasted until day 90 post-stroke.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:49:58.403222+00:00"}
{"study_id": 92330, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess acute responses to passive heat via lower-limb, hot-water immersion in patients with peripheral arterial disease (PAD) and healthy elderly controls.", "results_summary": "The study found that hot-water immersion increased shear rate and improved lower-limb perfusion, suggesting potential cardiovascular benefits for both PAD patients and healthy elderly individuals.", "population_specificity": "Patients with peripheral arterial disease (PAD) and healthy elderly controls.", "effective_dosage": "30-minute waist-level immersion in 42.1 \u00b1 0.6\u00b0C water.", "study_duration": "30 minutes.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:49:58.593424+00:00"}
{"study_id": 92331, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to determine if caregiver-mediated exercises (CME) improve functional ability and health-related quality of life in people with stroke and assess the effect on caregiver burden.", "results_summary": "The study found no significant effect of CME on basic or extended activities of daily living (ADL) but noted improvements in standing balance, quality of life, and Six-Minute Walking Test distance. Caregiver burden did not increase with CME.", "population_specificity": "Adults with stroke and their caregivers.", "effective_dosage": "Not specified", "study_duration": "Varies by study (not specified in abstract)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:50:02.631008+00:00"}
{"study_id": 92332, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to determine the impact of tricuspid regurgitation (TR) severity on functional outcomes, including 6-minute walking distance, in patients undergoing MitraClip procedures for mitral regurgitation.", "results_summary": "The study found that 6-minute walking distance significantly improved in patients with TR \u2264 II but not in those with TR > II, indicating that baseline TR severity influences functional outcomes post-MitraClip. Higher TR grades were also associated with increased mortality and worse NT-pro-BNP levels.", "population_specificity": "261 patients (mean age 76.6 \u00b1 10) with symptomatic mitral regurgitation, primarily functional MR (75.2%), undergoing MitraClip procedures.", "effective_dosage": "Not specified", "study_duration": "Follow-up period of 721 \u00b1 19.4 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:50:03.742505+00:00"}
{"study_id": 92333, "supplement_id": 1667, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy and cost-effectiveness of supervised exercise therapy (SET) for improving walking distance and health-related quality of life in patients with intermittent claudication (IC).", "results_summary": "SET was found to robustly alleviate claudication symptoms, improve walking distance, and enhance health-related quality of life, making it the most cost-effective treatment for IC. However, global implementation of SET is limited by barriers such as lack of specialized networks, physician awareness, and financial incentives.", "population_specificity": "Older patients with intermittent claudication (IC), often multimorbid and with atherosclerotic disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:50:04.609107+00:00"}
{"study_id": 92335, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine if snacking could prevent exercise-induced reductions in plasma glucose (PG) and limit post-exercise PG elevations in individuals with type 1 diabetes using closed-loop insulin delivery during brisk walking.", "results_summary": "Snacking during exercise prevented significant drops in PG (10 \u00b1 13 mg/dL increase vs. 53 \u00b1 10 mg/dL decrease without snacking) and eliminated hypoglycemia requiring rescue treatment. Insulin delivery was higher with snacking (1.8 \u00b1 0.4 U vs. 0.7 \u00b1 0.1 U).", "population_specificity": "12 individuals with type 1 diabetes, aged 13-36 years.", "effective_dosage": "Not specified (snacking strategy details not provided).", "study_duration": "105-minute exercise sessions.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:50:06.678327+00:00"}
{"study_id": 92337, "supplement_id": 1667, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of exercise therapy, including walking, on fatigue and other symptoms in patients with chronic fatigue syndrome (CFS) compared to other interventions or controls.", "results_summary": "Exercise therapy, including walking, reduced fatigue and improved sleep, physical functioning, and self-perceived health in CFS patients, with no evidence of worsening outcomes. Its effectiveness was similar to cognitive-behavioral therapy (CBT) and greater than pacing.", "population_specificity": "Adults with a primary diagnosis of chronic fatigue syndrome (CFS).", "effective_dosage": "Mixed intensity aerobic exercise (e.g., walking, swimming, cycling) for 12 to 26 weeks; exact walking dosage not specified.", "study_duration": "12 to 26 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:50:08.578625+00:00"}
{"study_id": 92338, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare functional independence changes after neurorehabilitation between patients with nontraumatic subarachnoid hemorrhage (SAH) and those with intracerebral hemorrhage (ICH) or acute ischemic stroke (AIS).", "results_summary": "Patients with nontraumatic SAH showed greater progress in functional independence during neurorehabilitation compared to ICH/AIS patients, particularly in specific FIM items like stair walking, but were discharged with lower overall functional levels. Both groups significantly improved their functional outcomes.", "population_specificity": "Patients with first-time nontraumatic SAH (n=212) and age-matched patients with first-time ICH/AIS (n=448).", "effective_dosage": "Not applicable", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:50:08.791086+00:00"}
{"study_id": 92339, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to review best practices for endoscopic lung volume reduction (ELVR) using Zephyr valves in patients with severe emphysema.", "results_summary": "The study found that ELVR with Zephyr valves improves pulmonary function, exercise capacity, and quality of life in selected emphysema patients without collateral ventilation. Complications like pneumothorax were noted but manageable.", "population_specificity": "Patients with severe emphysema (residual volume >175% predicted, FEV1 <50% predicted, 6-min walking distance >100 m) and no collateral ventilation.", "effective_dosage": "Not mentioned", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:50:10.537138+00:00"}
{"study_id": 92340, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether adding statins to standard treatment improves outcomes, including 6-minute walking distance, in adult patients with pulmonary hypertension.", "results_summary": "The study found that statins did not significantly improve 6-minute walking distance, reduce dyspnea scores, lower clinical worsening risk, or decrease systolic pulmonary arterial pressure in PH patients. Subgroup analysis for PH due to COPD or non-COPD also showed no significant benefits.", "population_specificity": "Adult patients with pulmonary hypertension (PH), including subgroups with PH due to COPD and non-COPD causes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:50:12.105345+00:00"}
{"study_id": 92342, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to determine if biofeedback during lower limb activities (including walking) is more effective than usual therapy in improving those activities post-stroke and whether benefits are maintained beyond the intervention.", "results_summary": "Biofeedback improved performance of lower limb activities more than usual therapy, with a standardized mean difference of 0.50 (95% CI 0.30 to 0.70). The study concluded that biofeedback is more effective but noted the need for further research on long-term effects.", "population_specificity": "People who have had a stroke.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:50:14.487700+00:00"}
{"study_id": 92344, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review studies measuring gait parameters and energy consumption in adolescents with idiopathic scoliosis (AIS) during walking without intervention.", "results_summary": "Most studies found no significant differences in walking speed, cadence, or step width between AIS patients and normal participants, but patients showed reduced hip/pelvic motion, higher energy cost, stepping asymmetry, and ground reaction force asymmetry.", "population_specificity": "Adolescents with idiopathic scoliosis (AIS).", "effective_dosage": "Not available", "study_duration": "Not applicable (literature review)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:50:15.817542+00:00"}
{"study_id": 92343, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the short-term effects of rectus femoris neurotomy for treating spastic stiff-knee gait in patients with hemiparesis.", "results_summary": "The study found significant improvements in maximal walking distance, gait speed, stride length, and kinematic parameters after rectus femoris neurotomy. Rectus femoris muscle activity during gait normalized, and early swing phase knee extension moment decreased.", "population_specificity": "Seven ambulatory patients with hemiparesis of spinal or cerebral origin and spastic stiff-knee gait.", "effective_dosage": "Not specified", "study_duration": "3 months post-intervention", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:50:16.750397+00:00"}
{"study_id": 92345, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether combined strength and endurance exercise training improves functional performance, including walking ability, in individuals with cerebral palsy.", "results_summary": "The exercise group showed significant improvements in walking ability (6-minute walk, 10-m walk), functional lower limb strength (30-second sit-to-stand), and balance (Functional Reach Test) compared to baseline and the control group.", "population_specificity": "Fifteen participants with spastic cerebral palsy.", "effective_dosage": "70 minutes per day, 3 days per week.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:50:18.321533+00:00"}
{"study_id": 92346, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the short-term effects of virtual walking integrated physiotherapy on pain, function, and kinesiophobia in patients with subacute and chronic non-specific low-back pain.", "results_summary": "Both groups improved, but the virtual walking group showed significantly better outcomes in pain (VAS), kinesiophobia (TKS), mobility (TUG), and endurance (6MWT). Virtual walking integrated physiotherapy was more effective than traditional physiotherapy for these parameters.", "population_specificity": "Patients with subacute and chronic non-specific low-back pain (44 participants, 22 per group).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:50:20.216253+00:00"}
{"study_id": 92347, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to synthesize the research literature on test protocols and measurement properties of time-limited walk tests in people poststroke.", "results_summary": "The study found strong evidence of the reliability and construct validity of the 6-minute walk test (6MWT) poststroke, with moderate-to-strong correlations between 6MWT distance and various functional measures. Protocol variations, such as walkway length and walking aid, influenced performance, highlighting the need for standardized protocols.", "population_specificity": "People poststroke (acute phase <1 month and beyond).", "effective_dosage": "Not applicable (walk tests, not a supplement).", "study_duration": "Not specified (systematic review of existing studies).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:50:22.978382+00:00"}
{"study_id": 92349, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "To determine the effectiveness of technology-based distance physical rehabilitation interventions in multiple sclerosis (MS) on physical activity and walking.", "results_summary": "Technology-based distance physical rehabilitation had a large effect on physical activity but no significant differences were observed in walking outcomes. Further research is needed to assess the impact on walking in MS.", "population_specificity": "Persons with multiple sclerosis (MS)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:50:23.255838+00:00"}
{"study_id": 92341, "supplement_id": 1667, "safety_score": "80", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to systematically review the safety and effectiveness of exercise, including walking, for improving joint function and recovery in people with haemophilia.", "results_summary": "Treadmill walking improved balance in children and increased peak torque of knee flexors and extensors when combined with other exercises. Partial weight-bearing exercises, including walking, improved walking tolerance and muscle strength compared to static exercises.", "population_specificity": "Males aged 8 to 49 years with haemophilia A or B of any severity.", "effective_dosage": "Not specified", "study_duration": "4 to 12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:50:23.895091+00:00"}
{"study_id": 92348, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to test the clinical utility of the 6-minute walk test (6MWT) for assessing walking capacity in patients with moderate Parkinson's disease (PD).", "results_summary": "The study found that the 6MWT was significantly correlated with the Timed 'Up & Go' test (TUG) and energy cost of walking (Ec), confirming its convergent validity and clinical utility for moderate PD patients. Multiple regression analysis showed TUG and Ec independently correlated with 6MWT results, while age, HY stage, and cadence were not.", "population_specificity": "24 patients with moderate Parkinson's disease (average Hoehn and Yahr stage 3.1\u00b10.5).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:50:24.449605+00:00"}
{"study_id": 92336, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to investigate the effects of early physical activity time (EPAT) on pain, recovery of daily living abilities, and vertebral collapse progression in patients with acute vertebral compression fractures (VCFs).", "results_summary": "EPAT was associated with better recovery of daily living abilities (mFIM scores) but showed no significant effect on pain reduction (VRS scores) or vertebral collapse progression. The active group had better functional gains compared to the sedentary group.", "population_specificity": "69 patients with acute VCFs treated conservatively at Nagasaki Memorial Hospital.", "effective_dosage": "Activity time corresponding to 1.8-8.3 metabolic equivalent activities during the first week after admission.", "study_duration": "4 weeks (assessments at weeks 0, 2, and 4).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:50:27.191501+00:00"}
{"study_id": 92350, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of HYADD4-G, a hyaluronic acid-based hydrogel, on improving pain and function in professional soccer players with knee chondropathy.", "results_summary": "The study found significant improvements in KOOS and VAS scores at 1, 3, and 6 months post-treatment, indicating reduced pain and enhanced joint function. Statistical analysis confirmed these improvements were significant (P<0.05).", "population_specificity": "Thirty male professional soccer players in the Italian League (2014-2015) with traumatic or degenerative knee chondropathy.", "effective_dosage": "3 mL of 8 mg/mL HYADD4-G, administered twice at a one-week interval.", "study_duration": "6 months (follow-up period after two injections).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:50:27.293242+00:00"}
{"study_id": 92351, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "To examine the effects of brisk walking combined with music in the evening on sleep quality in sedentary older adults with chronic insomnia.", "results_summary": "Brisk walking combined with music improved subjective sleep quality in adults with insomnia, though listening to soothing music before bedtime was more effective at reducing wake time after sleep onset compared to brisk walking.", "population_specificity": "Sedentary older adults (aged 50-75) with chronic insomnia in Taiwan.", "effective_dosage": "30 minutes per session (frequency not specified).", "study_duration": "Each intervention lasted 30 minutes, with two sessions separated by 1 week.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:50:28.292438+00:00"}
{"study_id": 92354, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to investigate the electromyographic cost, coactivation, and cost of transport during walking in chronic heart failure and heart transplant patients compared to healthy controls.", "results_summary": "The study found that chronic heart failure and heart transplant patients had higher electromyographic cost, leg coactivation, and cost of transport during walking compared to controls. The minimum electromyographic cost occurred at speeds higher than the self-selected walking speed in patients, unlike controls.", "population_specificity": "Twelve chronic heart failure patients, twelve healthy controls, and five heart transplant patients.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:50:32.367439+00:00"}
{"study_id": 92355, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to assess the feasibility and acceptability of a coaching intervention (Walk This Way) to reduce sedentary behavior and increase physical activity in people with serious mental illness (SMI).", "results_summary": "The study found that the Walk This Way intervention was feasible and acceptable, with secondary aims suggesting potential reductions in sedentary behavior and increases in activity levels, though specific efficacy results were not detailed in the abstract.", "population_specificity": "People with serious mental illness (psychosis, bipolar disorder, and major depressive disorder) who were overweight, at risk for or had diabetes, smoked tobacco, or had a sedentary lifestyle.", "effective_dosage": "Not specified (intervention included setting daily walking targets and weekly walking groups).", "study_duration": "17 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:50:33.098861+00:00"}
{"study_id": 92352, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether a targeted physiotherapy intervention (PUSH) was more effective than a non-specific intervention (PULSE) in restoring independent community ambulation in older adults after hip fracture.", "results_summary": "The study compared PUSH (aerobic conditioning, specificity of training, muscle overload) and PULSE (flexibility, range of motion exercises) in improving walking ability. Primary outcomes focused on the ability to walk 300+ meters in 6 minutes at 16 weeks, with additional measures including endurance, balance, and function.", "population_specificity": "Older adults (\u226560 years) recovering from hip fractures, previously community-dwelling and ambulatory without assistance.", "effective_dosage": "32 physiotherapy visits (2 per week for 16 weeks), plus dietary counseling and supplements (vitamin D, calcium, multivitamins).", "study_duration": "16 weeks (with follow-up at 40 weeks for a subset).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:50:33.162790+00:00"}
{"study_id": 92353, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the impact of individual shear rate therapy (ISRT) on nitric oxide levels in blood plasma and related molecular markers in peripheral blood mononuclear cells (PBMCs) in healthy subjects and PAD patients.", "results_summary": "Short-term ISRT reduced NOS2 expression in PBMCs, while long-term ISRT increased plasma nitrite levels in PAD patients, suggesting a vascular-stimulating effect comparable to physical exercise.", "population_specificity": "26 healthy subjects and 14 PAD patients with stable intermittent claudication.", "effective_dosage": "One session of treadmill training and one session of ISRT (short-term); 30 hours of long-term ISRT (specific frequency not detailed).", "study_duration": "Short-term: single sessions; long-term: 30 hours total.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:50:33.194497+00:00"}
{"study_id": 92356, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to compare bone microarchitecture, physical function, and fracture risk factors in elderly women with Type 2 diabetes mellitus (T2DM) versus nondiabetic controls.", "results_summary": "Women with T2DM had more favorable bone microarchitecture but reduced bone material strength and impaired physical function (e.g., slower walking speed, worse balance) compared to controls, potentially explaining their higher fracture risk.", "population_specificity": "Women aged 75\u201380 years in Gothenburg, Sweden (99 with T2DM, 954 controls).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:50:34.757984+00:00"}
{"study_id": 92357, "supplement_id": 1667, "safety_score": "90", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the effects of short-term interval walking training (IWT) and continuous walking training (CWT) on glycaemic control and oxidative stress levels in individuals with type 2 diabetes.", "results_summary": "IWT significantly reduced maximum glucose levels and glycaemic variability (MAGE), while CWT showed no significant changes. Neither intervention affected systemic oxidative stress levels or physical fitness.", "population_specificity": "Individuals with type 2 diabetes (n=14).", "effective_dosage": "Ten supervised treadmill sessions, 60 minutes per session (IWT: alternating 3 min at slow [58.9% peak oxygen consumption] and fast [90.0% peak oxygen consumption] walking speeds; CWT: moderate speed [75.6% peak oxygen consumption]).", "study_duration": "2 weeks per intervention, with 4-8 week washout periods.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:50:36.916388+00:00"}
{"study_id": 92334, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to determine whether staff-directed facilitation of early mobilization (walking) in an Enhanced Recovery Program (ERP) improves recovery outcomes after colorectal surgery compared to usual care.", "results_summary": "The study found that facilitated mobilization increased adherence to walking targets and step counts during the early postoperative days but did not improve recovery of walking capacity at 4 weeks or other outcomes. The intervention showed no significant long-term benefits despite short-term improvements in mobilization.", "population_specificity": "99 colorectal surgery patients (median age 63, 57% male, 80% laparoscopic) in an established ERP.", "effective_dosage": "Staff-assisted transfers and walking from postoperative days 0-3.", "study_duration": "Intervention administered from postoperative days 0-3.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:50:37.338537+00:00"}
{"study_id": 92358, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to examine the effect of interrupting prolonged sitting with brief bouts of walking or resistance activities on 22-hour glucose homeostasis in adults with type 2 diabetes.", "results_summary": "Both light-intensity walking (LW) and simple resistance activities (SRA) significantly reduced 22-hour glucose and nocturnal mean glucose concentrations compared to prolonged sitting, with improvements sustained until the following morning.", "population_specificity": "Inactive overweight/obese adults with type 2 diabetes (14 men; 62 \u00b1 6 years).", "effective_dosage": "3-minute bouts of light-intensity walking at 3.2 km/h every 30 minutes.", "study_duration": "7-hour laboratory conditions, with 22-hour glucose monitoring.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:50:37.569031+00:00"}
{"study_id": 92359, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to determine whether treadmill training with visual biofeedback improves gait symmetry and spatiotemporal/kinematic parameters in chronic stroke patients.", "results_summary": "Treadmill training improved gait symmetry (step length, stance phase time, inter-limb ratio) in the intervention group, with effects maintained at 6 months. No significant difference was found between the biofeedback and control groups.", "population_specificity": "Chronic stroke patients (n=30).", "effective_dosage": "Not specified (10-day rehabilitation program).", "study_duration": "10 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:50:40.759076+00:00"}
{"study_id": 92360, "supplement_id": 1667, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the biomechanical outcomes of using prosthetic knees and ankles with damping mechanisms compared to non-damped prostheses in individuals with lower limb amputation.", "results_summary": "The review found heterogeneous methodologies and inconsistent findings across studies, with only self-selected gait speed showing a consistent difference when dampers were applied. Further research is needed to clarify the benefits of damped prosthetic components.", "population_specificity": "Individuals with lower limb amputation.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:50:41.550207+00:00"}
{"study_id": 45834, "supplement_id": 1690, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether prebiotic-rich yogurt could improve metabolic indices and reduce menopausal symptoms in menopausal women compared to regular yogurt.", "results_summary": "The study found that prebiotic-rich yogurt significantly reduced menopausal symptoms (including anxiety, depression, and vasomotor symptoms) and lowered low-density lipoprotein levels, though it increased serum insulin levels compared to regular yogurt.", "population_specificity": "60 menopausal women", "effective_dosage": "100 g daily after lunch", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:50:48.977114+00:00"}
{"study_id": 45833, "supplement_id": 1690, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of yogurt (YG) on the gut microbiota and diarrhea symptoms in mice with antibiotic-associated diarrhea (AAD).", "results_summary": "Yogurt significantly reduced diarrhea scores, inhibited increases in cecum index and cecal length, and altered gut microbiota composition by increasing Firmicutes and decreasing Bacteroidetes and Bacteroidaceae. YG also reduced the abundance of Bacteroides or Parasutterella at the genus level.", "population_specificity": "Mice with antibiotic-associated diarrhea (AAD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:50:49.025040+00:00"}
{"study_id": 45830, "supplement_id": 1690, "safety_score": "85", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of probiotic yogurt versus ordinary yogurt on inflammatory, endothelial, lipid, and renal indices in patients with chronic heart failure (CHF).", "results_summary": "Probiotic yogurt significantly increased sTWEAK levels compared to ordinary yogurt, suggesting potential anti-inflammatory benefits in CHF patients. No significant differences were observed for other measured indices.", "population_specificity": "90 patients with chronic heart failure (CHF), 78 of whom completed the study.", "effective_dosage": "Not specified", "study_duration": "10 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:50:49.239854+00:00"}
{"study_id": 45836, "supplement_id": 1690, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the efficacy of low-fat yogurt fortified with nano-encapsulated vitamin D3 in reducing systemic inflammation in individuals with abdominal obesity.", "results_summary": "Fortified yogurt significantly reduced serum levels of neutrophils, lymphocytes, platelets, and RDW, as well as inflammatory ratios (NLR, PLR, RPR), indicating decreased inflammation in participants.", "population_specificity": "Abdominally obese participants", "effective_dosage": "150 g/day of low-fat yogurt fortified with 1500 IU nano-encapsulated vitamin D3", "study_duration": "2.5 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:50:49.528045+00:00"}
{"study_id": 45835, "supplement_id": 1690, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to examine the effect of probiotic yogurt consumption on liver enzymes, steatosis, and liver fibrosis in patients with non-alcoholic fatty liver disease (NAFLD).", "results_summary": "The study did not report specific results but proposed to evaluate biochemical indicators, insulin resistance, steatosis, and fibrosis before and after 12 weeks of probiotic yogurt consumption compared to plain yogurt.", "population_specificity": "Sixty-eight patients with NAFLD, block-matched for sex, BMI, and age.", "effective_dosage": "300 g/d probiotic yogurt containing 10^6 cfu/g of Lactobacillus acidophilus and Bifidobacterium lactis strains.", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:50:49.943573+00:00"}
{"study_id": 45837, "supplement_id": 1690, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the antibacterial and antibiofilm activity of a novel bacteriocin (LSX01) from Lactobacillus paracasei LS-6 against Staphylococcus aureus in dairy products.", "results_summary": "The study found that LSX01 exhibited strong antibacterial and antibiofilm effects against S. aureus, with a low minimum inhibitory concentration (16.90 \u03bcg/mL), broad-spectrum antimicrobial activity, and tolerance to heat and acid-base treatments. It also disrupted S. aureus cell membranes and inhibited biofilm formation.", "population_specificity": "Not specified (in vitro study on bacterial strains).", "effective_dosage": "Minimum inhibitory concentration of 16.90 \u03bcg/mL against S. aureus_45.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:50:50.181745+00:00"}
{"study_id": 45831, "supplement_id": 1690, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of sugar replacements (stevia, sucralose, and sorbitol) on the physicochemical, microbiological, microstructural, and sensory characteristics of probiotic-frozen yogurt.", "results_summary": "The study found that sugar replacements (stevia, sucralose, and sorbitol) maintained probiotic viability (>6.00 log10 CFU g\u22121) for up to 60 days and improved overrun, hardness, and viscosity compared to sucrose. Sensory acceptability was highest in treatments with sweeteners (F3, F4, F2).", "population_specificity": "Consumers seeking sugar-free probiotic-frozen yogurt, particularly those with lactose intolerance or metabolic syndrome.", "effective_dosage": "Not specified (four treatments with varying sweeteners).", "study_duration": "60 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:50:50.579634+00:00"}
{"study_id": 45832, "supplement_id": 1690, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether a synbiotic yogurt (containing inulin and Lactobacillus rhamnosus GG) enhances calcium absorption compared to a control yogurt in young adult women.", "results_summary": "The synbiotic yogurt showed a trend toward higher calcium absorption (1.24 ratio in 0-36-h urine pool) compared to the control yogurt, with about two-thirds of participants responding positively. Responders had higher vegetable intake and tended to have higher potassium and calcium intakes.", "population_specificity": "Normal-weight young adult women (25.0 \u00b1 3.5 years, n = 30).", "effective_dosage": "185 mL daily, containing 4 g inulin and >1 \u00d7 10^7 CFU/mL Lactobacillus rhamnosus GG.", "study_duration": "3 weeks (crossover study).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:50:50.733076+00:00"}
{"study_id": 45840, "supplement_id": 1690, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the anti-diabetic effects of yak yogurt-derived Lactobacillus plantarum SHY130 and its potential mechanisms in high-fat diet and streptozotocin-induced diabetic mice.", "results_summary": "L. plantarum SHY130 improved blood glucose regulation, reduced insulin resistance, preserved pancreatic \u03b2-cell mass, increased SCFA receptor expression, and modulated gut microbiota to enhance SCFA-producing bacteria in diabetic mice.", "population_specificity": "C57BL/6J mice with high-fat diet and streptozotocin-induced type 2 diabetes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:50:56.586630+00:00"}
{"study_id": 200629, "supplement_id": 1690, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate whether vitamin D-supplemented yogurt could reduce Candida infections in critically ill children on broad-spectrum antibiotics.", "results_summary": "The study found that vitamin D-supplemented yogurt significantly reduced candiduria and candidaemia cases compared to plain yogurt, and shortened PICU stays, though mortality rates were similar between groups.", "population_specificity": "Children aged 12 months to 5 years admitted to a pediatric intensive care unit (PICU) on broad-spectrum antibiotic therapy.", "effective_dosage": "300 IU/day of vitamin D in yogurt.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:50:56.984550+00:00"}
{"study_id": 45841, "supplement_id": 1690, "safety_score": "90", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of non-fat, conventional yogurt consumption on appetite hormone responses in overweight patients with type 2 diabetes mellitus (T2DM) following a non-energy-restricted diet.", "results_summary": "The study found no significant differences in glucose, insulin, ghrelin, GLP-1, PYY responses, or subjective appetite ratings after 12 weeks of yogurt consumption. Regular consumption of non-fat yogurt did not affect appetite hormone responses in the studied population.", "population_specificity": "Overweight patients with type 2 diabetes mellitus (T2DM).", "effective_dosage": "2 meals/day (2 \u00d7 200 g) of yogurt.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:50:57.402680+00:00"}
{"study_id": 45838, "supplement_id": 1690, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the effects of higher-pressure homogenization and extended shelf life (ESL) processing on the curd structure and texture of set yogurt.", "results_summary": "The study found that smaller fat globule sizes (<0.6 \u00b5m) achieved via high-pressure homogenization (35 MPa + 5 MPa) improved curd hardness and firmness in ESL-processed yogurt, making it suitable for commercial transport while maintaining smooth texture. Sensory evaluation scores were significantly favorable for yogurt produced with this method.", "population_specificity": "Not specified (laboratory study on yogurt samples)", "effective_dosage": "Not applicable (processing conditions: 35 MPa first stage, 5 MPa second stage homogenization; heat treatments varied)", "study_duration": "Not specified (fermentation and evaluation timeframe not detailed)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:50:57.904260+00:00"}
{"study_id": 48722, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The study aimed to investigate the mechanism of action of GFAP in tic disorder and its potential influence on neuroprotection and behavior improvement.", "results_summary": "The study found that GFAP intervention reduced the frequency and intensity of convulsions, suggesting a neuroprotective effect, possibly through modulation of inflammatory signaling pathways like NF-\u03baB.", "population_specificity": "Not specified (animal or human study not clearly stated in the abstract).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:50:57.908673+00:00"}
{"study_id": 200632, "supplement_id": 1690, "safety_score": "40", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to assess the safety and efficacy of a Hoodia gordonii purified extract (HgPE) formulated in a yogurt drink for weight management in overweight women.", "results_summary": "The study found that HgPE in yogurt was less well tolerated than placebo, causing nausea, vomiting, and skin sensation disturbances, with no significant effects on energy intake or body weight. Adverse changes in vital signs and lab parameters were observed in the HgPE group.", "population_specificity": "Healthy, overweight women stratified by percentage body fat.", "effective_dosage": "1110 mg HgPE twice daily (before breakfast and dinner).", "study_duration": "15 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:50:58.216711+00:00"}
{"study_id": 200631, "supplement_id": 1690, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness of probiotic goat yogurt supplemented with Bifidobacterium longum in treating pediatric functional chronic intestinal constipation (FCIC).", "results_summary": "Both probiotic and non-supplemented yogurt improved defecation frequency and pain, but the probiotic group showed significantly greater improvements in stool consistency, defecation pain, and abdominal pain. The benefits of probiotic supplementation were more pronounced in the first phase of the study.", "population_specificity": "59 students aged 5-15 years with FCIC, diagnosed using Roma III criteria.", "effective_dosage": "10^9 colony-forming units/mL of Bifidobacterium longum daily.", "study_duration": "5 weeks per treatment phase, with a crossover after the first phase (total 10 weeks).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:50:58.880148+00:00"}
{"study_id": 200630, "supplement_id": 1690, "safety_score": "90", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the effect of Bifidobacterium animalis ssp. lactis Bf-6-supplemented yogurt on colonic transit time in women with a history of straining during bowel movements or hard stools.", "results_summary": "The study found no significant difference in colonic transit time between the active and control periods in the cross-over trial, but analysis of period 1 alone showed a significant reduction in transit time with the active yogurt (35.2 h vs. 52.9 h). Few adverse events were reported, with no differences between groups.", "population_specificity": "Sixty-eight generally healthy women with a self-reported history of straining during bowel movements or hard/lumpy stools in the past 2 years.", "effective_dosage": "Not specified in the abstract.", "study_duration": "14 days per treatment period, with a 6-week washout between treatments.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:50:59.388841+00:00"}
{"study_id": 48723, "supplement_id": 1691, "safety_score": "65", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review Yohimbine's therapeutic potential, safety profile, and strategies to enhance bioavailability while reducing toxicity.", "results_summary": "Yohimbine shows promise for treating erectile dysfunction and metabolic disorders but has toxicological concerns at higher doses. Ongoing research is needed to fully assess its efficacy and safety.", "population_specificity": "Not specified (general review of existing research).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:51:03.389285+00:00"}
{"study_id": 48724, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate Yohimbine's anti-inflammatory, anti-oxidant, and anti-fibrotic effects in LPS/TGF-\u03b2-induced cell differentiation and bleomycin-induced pulmonary fibrosis in rats.", "results_summary": "Yohimbine significantly reduced inflammatory, oxidative stress, and fibrotic markers in both cell and rat models, improved lung architecture, and restored lung function dose-dependently by regulating the MAPK pathway.", "population_specificity": "BEAS-2B/LL29 cells and bleomycin-induced pulmonary fibrosis model in rats.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:51:04.685686+00:00"}
{"study_id": 48725, "supplement_id": 1691, "safety_score": "85", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to investigate the pharmacokinetic interactions between clomipramine and yohimbine and evaluate their combined safety profile.", "results_summary": "The study found a clinically significant drug-drug interaction for yohimbine when combined with clomipramine, likely due to competitive inhibition of yohimbine metabolism by clomipramine. Both drugs were safe and well-tolerated in mono- and combination therapy, with no major adverse events reported.", "population_specificity": "15 healthy male subjects", "effective_dosage": "Not specified", "study_duration": "Single-dose and steady-state pharmacokinetics assessed over 24 hours", "interactions": "Clomipramine competitively inhibits yohimbine metabolism, likely mediated by cytochrome P450 2D6.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:51:05.955021+00:00"}
{"study_id": 48726, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential of yohimbine as a repurposed anticancer drug, specifically its effects on DMBA-induced oral cancer in hamsters.", "results_summary": "Yohimbine significantly restored detoxification enzyme activities, reduced oxidative stress markers, and downregulated inflammatory and proliferative markers (COX-2, IL-6, PCNA, cyclin D1) in DMBA-treated hamsters, suggesting anticancer potential.", "population_specificity": "Hamsters with DMBA-induced buccal pouch carcinogenesis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:51:06.799747+00:00"}
{"study_id": 48729, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the therapeutic effect of yohimbine against LPS-induced myocarditis in a rat model and assess its anti-inflammatory activity in vitro.", "results_summary": "Yohimbine significantly reduced LPS-induced inflammatory markers, improved cardiac parameters, mitigated apoptosis in myocardial cells, and ameliorated histopathological abnormalities, partly by modulating the MAPK pathway.", "population_specificity": "Rats with LPS-induced myocarditis and RAW 264.7 and H9C2 cells in vitro.", "effective_dosage": "2.5, 5, and 10 mg/kg for 12 hours.", "study_duration": "12 hours.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:51:07.436023+00:00"}
{"study_id": 48728, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to investigate the influence of yohimbine, alone and combined with hydrocortisone, on selective attention processes to fearful faces and related neuronal activation.", "results_summary": "The study found no differences between yohimbine and placebo groups in selective attention or neuronal activation, indicating no significant effect of yohimbine on the measured outcomes. Attentional bias toward fearful faces was observed across all groups, with related activation in the left cuneus.", "population_specificity": "167 healthy men aged 18-35 years (mean age 25.23 \u00b1 4.24 years).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:51:07.477197+00:00"}
{"study_id": 48727, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine how Yohimbine (YHB) inhibits the proliferation and migration of vascular smooth muscle cells (VSMCs) induced by platelet-derived growth factor (PDGF) and its underlying transcriptional regulatory mechanisms.", "results_summary": "YHB downregulated cell cycle regulatory proteins (PCNA, cyclin D1, CDK4, cyclin E) via FOXO3a modulation, reduced p-38 and mTOR phosphorylation, and significantly decreased FAK phosphorylation (especially at Y925) and paxillin expression, leading to inhibited VSMC proliferation and migration. Co-treatment with mTOR or p38 inhibitors enhanced these effects.", "population_specificity": "Vascular smooth muscle cells (VSMCs) induced by PDGF.", "effective_dosage": "Not specified (dose-dependent effects noted).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:51:07.997531+00:00"}
{"study_id": 48730, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the anti-fibrotic, anti-inflammatory, and antioxidant effects of Yohimbine hydrochloride (YHC) in chronic liver injury models.", "results_summary": "YHC significantly reduced inflammatory and fibrotic markers in vitro and in vivo, mitigated oxidative stress, and improved survival in rats by modulating the JNK/Wnt/\u03b2-catenin pathway.", "population_specificity": "HLECs, HSC-LX2, HepG2 cells, and thioacetamide-induced hepatic fibrosis rat models.", "effective_dosage": "Dose-dependent (specific amounts not provided).", "study_duration": "5 weeks (inflammation model) and 9 weeks (fibrosis model) in rats.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:51:08.361284+00:00"}
{"study_id": 48732, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine how oxytocin affects yohimbine-induced reinstatement of ethanol-seeking behavior in female rats.", "results_summary": "Yohimbine significantly increased lever responses, indicating reinstatement of ethanol-seeking behavior in female rats. Oxytocin administration, both systemically and in the central amygdala, attenuated this yohimbine-induced effect.", "population_specificity": "Adult female rats", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:51:11.250915+00:00"}
{"study_id": 48731, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the density of \u03b12-adrenergic receptors (ARs) using PET imaging with 11C-yohimbine in Parkinson's disease patients compared to healthy controls.", "results_summary": "The study found reduced 11C-yohimbine binding in cortical regions, thalamus, and putamen in Parkinson's patients, with specific reductions linked to tremor and anxiety symptoms. These results suggest noradrenergic dysfunction in Parkinson's disease.", "population_specificity": "30 Parkinson's disease patients and 30 age- and sex-matched healthy controls.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:51:12.356318+00:00"}
{"study_id": 48733, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to identify a multitargeted anticancer compound by screening phytobioactive chemicals, focusing on yohimbine's binding affinity and stability with key protein targets.", "results_summary": "Yohimbine exhibited the lowest docking scores (-8.3 to -10.0 kcal/mol) and stable binding with all studied protein targets, particularly ERK2, PARP1, and PIK3\u03b1, suggesting it as a potent lead molecule for anticancer therapy.", "population_specificity": "In silico (computational) study, no human or animal subjects.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:51:13.456310+00:00"}
{"study_id": 48734, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the anticancer potential of yohimbine in drug-resistant oral cancer KB-ChR-8-5 cells.", "results_summary": "Yohimbine demonstrated dose-dependent cytotoxicity with an IC50 of 44 \u00b5M, induced apoptosis, increased ROS generation, and modulated mitochondrial membrane potential in KB-ChR-8-5 cells.", "population_specificity": "Drug-resistant oral cancer KB-ChR-8-5 cell lines.", "effective_dosage": "40 \u00b5M and 50 \u00b5M.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:51:14.396301+00:00"}
{"study_id": 48735, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess yohimbine's binding phenomenon with hemoglobin and its molecular mechanism, correlating structure-function relationships for drug design.", "results_summary": "The study found that yohimbine successfully binds to hemoglobin with high affinity (10^5 M^-1) through static quenching, driven by hydrophobic forces and hydrogen bonding, and the interaction was spontaneous and exothermic. Structural analysis showed significant perturbation of hemoglobin upon yohimbine binding.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:51:15.263960+00:00"}
{"study_id": 48736, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether yohimbine modulates long-term fear conditioning and extinction in humans by enhancing noradrenergic activity.", "results_summary": "Yohimbine increased salivary alpha-amylase activity, indicating enhanced noradrenergic release, and elevated fear-conditioned bradycardia and electrophysiological signatures, suggesting it strengthened fear memory consolidation.", "population_specificity": "51 healthy male students explicitly aware of stimulus contingencies.", "effective_dosage": "10 mg (single dose).", "study_duration": "Single administration between fear acquisition and extinction, with recall assessed 1 day later.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:51:15.415268+00:00"}
{"study_id": 48738, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the efficacy of Yohimbine as a pharmacological treatment for erectile dysfunction (ED) by analyzing randomized controlled trials comparing it to placebo or no treatment.", "results_summary": "Yohimbine alone and in combination significantly improved erectile function compared to placebo, but alone did not significantly improve sexual function. Combined treatments showed higher efficacy in improving sexual function.", "population_specificity": "Patients with erectile dysfunction (ED).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:51:15.454568+00:00"}
{"study_id": 48739, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to investigate Yohimbine's antidepressant activity through molecular docking, pharmacokinetic analyses, and in silico mutational studies targeting the 5HT1A receptor.", "results_summary": "Yohimbine demonstrated good drug-likeness and pharmacokinetic properties, with strong docking scores and hydrogen-bond interactions with the 5HT1A receptor, suggesting substantial efficacy against MDD, though further bench studies are needed for confirmation.", "population_specificity": "In silico (computational) study, no human or animal subjects.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:51:21.769660+00:00"}
{"study_id": 48740, "supplement_id": 1691, "safety_score": "30", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to explore the electrophysiological effects of Yohimbine on human cardiomyocytes using hiPSC-CMs to assess potential cardiotoxicity.", "results_summary": "Yohimbine inhibited spontaneous action potentials, prolonged action potential duration, and negatively affected sodium and calcium channel currents in hiPSC-CMs, indicating direct cardiotoxic effects not mediated by \u03b12-adrenoceptor signaling.", "population_specificity": "Human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs)", "effective_dosage": "Low doses (IC50 = 14.2 \u03bcM for INa), high doses (IC50 = 139.7 \u03bcM for ICa)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:51:23.492848+00:00"}
{"study_id": 48742, "supplement_id": 1691, "safety_score": "20", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to investigate severe poisoning and death cases associated with yohimbine use.", "results_summary": "The study found high concentrations of yohimbine in the blood of four poisoned individuals, with one fatality linked to extremely elevated levels (5631 ng/mL). Autopsy and toxicological analysis ruled out other causes, suggesting yohimbine poisoning as the likely cause of death.", "population_specificity": "Four middle-aged men (aged 47-65) suspected of yohimbine poisoning.", "effective_dosage": "Not specified (blood concentrations: 249-5631 ng/mL).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:51:24.712848+00:00"}
{"study_id": 48743, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to identify new compounds derived from yohimbine with selective antagonistic activities against GPCRs relevant to cancer treatment.", "results_summary": "Several yohimbine analogues showed differential antagonistic activities against GPCRs, with Y7g exhibiting selective antagonism against AVPR2 (IC50 = 459 nM) and OXTR (IC50 = 1.16 \u00b5M), potentially linking its anti-cancer activity to GPCR antagonism.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:51:24.927710+00:00"}
{"study_id": 48741, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate yohimbine's inhibitory effect on benign prostatic hyperplasia (BPH) and explore its underlying mechanisms, particularly its impact on the steroid 5\u03b1-reductase pathway.", "results_summary": "Yohimbine significantly inhibited prostatic index increase in BPH rats (46.7\u201369.3% across doses) and reduced levels of key biomarkers (dihydrotestosterone, prostatic acid phosphatase, prostate-specific antigen, proliferating cell nuclear antigen, and steroid 5\u03b1-reductase), suggesting therapeutic benefits via the steroid 5\u03b1-reductase pathway.", "population_specificity": "Male rats with testosterone-induced BPH.", "effective_dosage": "2, 4, and 8 mg/kg administered daily.", "study_duration": "6 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:51:24.997133+00:00"}
{"study_id": 48745, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to validate two new HPLC methods for determining drugs used in treating male sexual disorders, including Yohimbine, while comparing the performance of core-shell and monolithic columns for greener chromatography.", "results_summary": "The study found that core-shell columns offered higher efficiency and resolution, while monolithic columns allowed greener solvent use at higher flow rates. Both methods successfully determined the drugs in pharmaceutical forms, counterfeit products, and human plasma.", "population_specificity": "Not specified (focused on analytical methodology, not human subjects).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:51:25.201179+00:00"}
{"study_id": 48744, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether yohimbine has a renoprotective effect on lipopolysaccharide (LPS)-induced acute kidney injury (AKI) in rats.", "results_summary": "Yohimbine treatment improved kidney function, reduced inflammatory markers (such as cytokines and iNOS), enhanced anti-inflammatory IL-10 expression, and blocked NF-\u03baB nuclear localization. It also improved blood pressure and activated ERK/CREB phosphorylation pathways.", "population_specificity": "Male Sprague Dawley rats", "effective_dosage": "0.1 or 0.5 mg/kg, intraperitoneal (i.p.)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:51:25.824172+00:00"}
{"study_id": 48737, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to examine the effects of a single acute dose of yohimbine hydrochloride on repeated anaerobic sprint ability in physically active females.", "results_summary": "Yohimbine significantly improved mean power, total work, and heart rate while reducing fatigue index and post-exercise lactate levels compared to placebo. It also increased epinephrine concentrations but did not affect norepinephrine or rate of perceived exertion.", "population_specificity": "Physically active females (n = 18)", "effective_dosage": "2.5 mg (single dose)", "study_duration": "Acute (single dose administered 20 minutes before exercise)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:51:26.009402+00:00"}
{"study_id": 48751, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to determine the exact amounts of yohimbine free base in various formulations and validate a method for its quantification.", "results_summary": "The study found that all tested formulations contained yohimbine, though some had lower concentrations than labeled. A validated densitometric HPTLC method was used to measure yohimbine content after acid-base purification.", "population_specificity": "Not specified (study focused on formulations, not human subjects).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:51:32.619520+00:00"}
{"study_id": 48746, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to understand the neural mechanisms by which yohimbine induces reinstatement of alcohol seeking and the associated patterns of brain activation.", "results_summary": "Yohimbine increased Fos-protein expression in stress/impulsivity centers (prefrontal cortex, extended amygdala) in a non-drug context and recruited additional brain regions (thalamus, hypothalamus, hippocampus) during alcohol-seeking reinstatement. Fos-protein correlations were stronger during reinstatement compared to home-cage administration.", "population_specificity": "Alcohol-experienced alcohol-preferring rats", "effective_dosage": "1 mg/kg (intraperitoneal)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:51:33.377513+00:00"}
{"study_id": 48752, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of yohimbine on neuronal spiking activity in the anterior cingulate cortex (ACC) and basolateral amygdala (BLA) between sham-lesioned and hemiparkinsonian rats.", "results_summary": "Yohimbine treatment (5mg/kg, SubQ) reduced neuronal spiking activity in the BLA of sham-lesioned rats but had no effect in hemiparkinsonian rats. Yohimbine did not affect ACC neuronal spiking activity in either group.", "population_specificity": "Anesthetized sham-lesioned and hemiparkinsonian rats", "effective_dosage": "5mg/kg, SubQ", "study_duration": "Single administration", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:51:34.107662+00:00"}
{"study_id": 48747, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Yohimbine enhances the effectiveness of virtual reality exposure therapy (VRET) for specific phobia by elevating norepinephrine and improving emotional memory.", "results_summary": "The study found no significant differences in outcomes between VRET with Yohimbine, VRET with propranolol, and VRET with placebo, suggesting Yohimbine did not enhance therapeutic effects beyond VRET alone.", "population_specificity": "Fifty-six participants with specific phobia.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Three sessions of VRET over two weeks.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:51:34.331423+00:00"}
{"study_id": 48748, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether yohimbine could augment prolonged exposure therapy for PTSD by increasing arousal during exposure and improving treatment outcomes.", "results_summary": "Yohimbine increased objective and subjective arousal during exposure and reduced trauma-cued heart-rate reactivity one week later. It also improved between-session habituation and depression symptoms but did not significantly affect PTSD symptoms over the course of treatment.", "population_specificity": "26 males with combat-related PTSD", "effective_dosage": "One-time dose (specific amount not provided)", "study_duration": "Single dose prior to first imaginal exposure, followed by standard prolonged exposure therapy", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:51:35.741517+00:00"}
{"study_id": 48753, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the effectiveness of enteral yohimbine as a treatment for severe amitraz poisoning in a pediatric case.", "results_summary": "The child regained consciousness within 18 hours after yohimbine administration and was successfully weaned off mechanical ventilation, suggesting yohimbine may be effective in managing amitraz poisoning.", "population_specificity": "A 3-year-old child with severe amitraz poisoning.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:51:35.967800+00:00"}
{"study_id": 48749, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to compare the antagonistic potency and anti-aggregation effects of aroxyalkyl derivatives of 2-methoxyphenylpiperazine, including Yohimbine, at 5-HT2A and \u03b12-adrenoceptors.", "results_summary": "Yohimbine showed moderate antagonistic effects at \u03b12-adrenoceptors but was less potent than compound MH-77 in inhibiting collagen-stimulated platelet aggregation. It also inhibited 5-HT/adrenaline-, ADP-, or collagen-induced platelet aggregation.", "population_specificity": "Rat models (in vitro and in vivo)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:51:36.704412+00:00"}
{"study_id": 48750, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to examine the effects of gonadal hormones and Yohimbine on ethanol-seeking behavior in male and female rats, focusing on reinstatement as a model of craving-like behavior.", "results_summary": "Yohimbine, combined with cues, induced reinstatement of ethanol seeking, but neither prior chronic nor acute hormone manipulations altered this effect. Blockade of estrogen receptors slightly reduced reinstatement in intact females.", "population_specificity": "Male and female rats (rodent model).", "effective_dosage": "Not specified.", "study_duration": "Three weeks of operant ethanol self-administration, followed by extinction training and acute hormone manipulation.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:51:36.984403+00:00"}
{"study_id": 48755, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to assess the therapeutic effects of yohimbine, alone and combined with naloxone, on PCOS-related body weight and endocrinological parameters in a rabbit model.", "results_summary": "Yohimbine treatment showed a descending trend in most PCOS-related parameters (luteinizing hormone, insulin) compared to the positive control, except for estradiol. Combined yohimbine and naloxone therapy improved clinical manifestations of PCOS.", "population_specificity": "Adult, reproductively mature female rabbits (Oryctolagus cuniculus) with induced PCOS.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:51:41.655714+00:00"}
{"study_id": 48754, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to develop a novel analytical method (SPME-HPLC) for pharmacokinetic study of yohimbine in human plasma.", "results_summary": "The study successfully developed a PEEK tube-based SPME-HPLC method with high enrichment efficiency, wide linear range (2-1000 ng/mL), and low detection limit (0.1 ng/mL) for yohimbine analysis in plasma. The method was applied to a pharmacokinetic study, with results compared to existing methods.", "population_specificity": "Human plasma samples (specific population not detailed).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:51:41.740043+00:00"}
{"study_id": 48756, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether berberine combined with yohimbine (BY) could reduce neutrophil tissue infiltration and multiple organ damage in septic mice, and to explore the mechanisms involved.", "results_summary": "BY therapy attenuated neutrophil infiltration and organ injury in septic mice, partly through IL-10-mediated inhibition of CCR2 expression in circulating neutrophils. These effects were reversed by IL-10 antibody pretreatment, though some chemokine reductions persisted.", "population_specificity": "Septic mice induced by cecal ligation and puncture (CLP).", "effective_dosage": "Not specified", "study_duration": "Administered 2 hours after CLP, with follow-up measurements at 6 hours.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:51:43.078181+00:00"}
{"study_id": 48757, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether yohimbine, an \u03b12-adrenoceptor antagonist, could attenuate kidney injury and reduce renal venous norepinephrine levels in rats with acute ischaemia/reperfusion-induced kidney injury.", "results_summary": "Yohimbine (0.1mg/kg) significantly reduced kidney injury and renal venous norepinephrine levels compared to controls. The protective effect was linked to \u03b12C-adrenoceptor inhibition, as selective \u03b12C-antagonists replicated these benefits, while \u03b12A- and \u03b12B-antagonists did not.", "population_specificity": "Rats with induced acute kidney injury via renal ischaemia/reperfusion.", "effective_dosage": "0.1mg/kg (single intravenous dose).", "study_duration": "Single dose administered 5 minutes prior to ischaemia.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:51:43.190828+00:00"}
{"study_id": 48760, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to examine the impact of yohimbine, a pharmacological stressor and alpha-2 adrenergic receptor antagonist, on executive function in cocaine-dependent men and women during cocaine cue exposure.", "results_summary": "Yohimbine reduced omission errors in cocaine-dependent individuals but increased commission errors in healthy controls. Cocaine-dependent women showed more omission errors and slower reaction times compared to cocaine-dependent men.", "population_specificity": "Cocaine-dependent men (n=12), cocaine-dependent women (n=27), control men (n=31), and control women (n=25).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:51:44.243471+00:00"}
{"study_id": 48758, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the antioxidant and anti-inflammatory effects of Yohimbine hydrochloride (YCL) in collagen-induced arthritis (CIA) in Wistar rats to assess its potential as an anti-RA treatment.", "results_summary": "YCL significantly reduced inflammatory markers (articular elastase, LPO, catalase) and improved antioxidant levels (GSH, SOD), while also decreasing expression of proinflammatory cytokines (COX-2, TNF-\u03b1, NF-\u0138B) and ameliorating joint damage in rats with CIA.", "population_specificity": "Wistar rats with collagen-induced arthritis (CIA).", "effective_dosage": "5 and 10 mg/kg body weight, once daily.", "study_duration": "28 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:51:44.580861+00:00"}
{"study_id": 48759, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the central mechanisms by which prazosin and doxazosin (alpha-1 antagonists) reduce yohimbine-induced reinstatement of alcohol seeking in rats.", "results_summary": "Yohimbine-induced reinstatement of alcohol seeking was significantly reduced by both ICV and systemic prazosin (50-69% decreases) and doxazosin (78% decrease). Prazosin also reduced yohimbine-induced Fos expression in key brain regions, suggesting central action.", "population_specificity": "Rats trained to self-administer alcohol.", "effective_dosage": "Yohimbine (1.25 mg/kg), prazosin (ICV: 2 and 6 nmol; systemic: 1 mg/kg), doxazosin (1.25, 2.5, and 5 mg/kg).", "study_duration": "Not explicitly stated in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:51:45.398270+00:00"}
{"study_id": 48761, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether yohimbine enhances the antidepressant-like effects of Sanggenon G and fluoxetine in rats subjected to forced swim test-induced depression.", "results_summary": "Yohimbine significantly enhanced the antidepressant-like effects of both fluoxetine and Sanggenon G, reducing immobility time in rats. The effect was dose-dependent, with notable improvements at 5, 10, and 20 mg/kg for fluoxetine and at 5 and 10 mg/kg for Sanggenon G.", "population_specificity": "Rats subjected to forced swim test-induced depression.", "effective_dosage": "5, 10, and 20 mg/kg (for fluoxetine); 5 and 10 mg/kg (for Sanggenon G).", "study_duration": "Not specified in the abstract.", "interactions": "Enhanced effects of fluoxetine and Sanggenon G when pretreated with yohimbine.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:51:47.266351+00:00"}
{"study_id": 48762, "supplement_id": 1691, "safety_score": "60", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to compare the effectiveness and safety of yohimbine and guanfacine as \u03b12-adrenoceptor ligands in reducing body mass and their anorectic activity.", "results_summary": "Yohimbine showed anorectic activity and significantly reduced intraperitoneal adipose tissue, with a beneficial effect on lipid profiles. However, it was less effective than guanfacine, and its \u03b11-adrenoceptor blockade was linked to side effects but also improved lipid profiles.", "population_specificity": "Wistar rats with high-fat diet-induced obesity.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:51:49.268624+00:00"}
{"study_id": 48763, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether \u03b12 adrenoceptor antagonism by yohimbine could enhance the anxiolytic-like effects of the SSRI fluoxetine in a preclinical anxiety model.", "results_summary": "The study found that combining yohimbine with fluoxetine produced a significantly greater reduction in water intake (an anxiolytic-like effect) than fluoxetine alone, suggesting yohimbine may enhance SSRI efficacy.", "population_specificity": "Rats in a schedule-induced polydipsia paradigm (a preclinical anxiety model).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Daily administrations (exact duration not specified in the abstract).", "interactions": "Enhanced effects when combined with fluoxetine.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:51:50.064584+00:00"}
{"study_id": 48765, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of yohimbine on anxiety-related behaviors in zebrafish larvae under normal and stressful conditions.", "results_summary": "Low doses of yohimbine reduced anxiety-related behaviors (anxiolytic) under normal conditions, while high doses increased anxiety (anxiogenic) in older larvae. Under stressful conditions, yohimbine generally increased anxiety-related behaviors in a dose-dependent manner.", "population_specificity": "AB strain zebrafish larvae at 5 and 7 days postfertilization (dpf).", "effective_dosage": "Different concentrations (specific amounts not provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:51:51.980346+00:00"}
{"study_id": 48764, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether yohimbine, as an adjunct to imipramine, accelerates behavioral and neurogenic effects in the hippocampus and identify its molecular and cellular targets.", "results_summary": "Yohimbine combined with imipramine (Y+I) enhanced neurogenic effects and modulated genes related to intracellular signaling, stress responses, and neuropeptide pathways, similar to fast-acting electroconvulsive seizure (ECS) but distinct from chronic imipramine treatment. The combination also reduced expression of receptors linked to antidepressant action (Adra2a, Htr2c, Sstr1) and regulated key signaling pathway genes (Impa2, Dio3, Rgs4, Acer2, Dclk2, Nfkbia, Sgk1).", "population_specificity": "Adult rats", "effective_dosage": "Not specified", "study_duration": "7 days", "interactions": "Imipramine (co-administered)", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:51:52.654310+00:00"}
{"study_id": 48767, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine if yohimbine, when administered after alcohol cue exposure sessions of varying durations, could alter alcohol cue-induced responding and self-administration in rats.", "results_summary": "The study found that neither yohimbine nor propranolol had subsequent effects on cue-induced responding or alcohol self-administration, suggesting limited efficacy in this context.", "population_specificity": "Rats trained to respond for alcohol in a controlled experimental setting.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:51:52.709655+00:00"}
{"study_id": 48766, "supplement_id": 1691, "safety_score": "60", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to examine the impact of yohimbine, a pharmacological stressor, on subjective, endocrine, and physiological responses to cocaine-paired cues in cocaine-dependent men and women compared to controls.", "results_summary": "Yohimbine increased anxiety, craving, and stress hormone levels, with stronger effects in women. It also heightened heart rate responses more in women than men, suggesting gender differences in stress-induced vulnerability to craving and relapse.", "population_specificity": "Cocaine-dependent men (n=32), cocaine-dependent women (n=30), control men (n=32), and control women (n=25).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:51:53.035092+00:00"}
{"study_id": 48769, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to determine whether combining yohimbine HCL with prolonged exposure therapy could enhance treatment outcomes for veterans with PTSD.", "results_summary": "The abstract does not report specific results regarding yohimbine's effects, as the study is proposed rather than completed.", "population_specificity": "40 veterans with PTSD", "effective_dosage": "Single administration (specific dosage not mentioned)", "study_duration": "Paired with the first session of imaginal exposure (duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:51:54.209508+00:00"}
{"study_id": 48768, "supplement_id": 1691, "safety_score": "85", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to determine whether yohimbine could effectively augment exposure therapy for social anxiety disorder, particularly its impact on self-reported and clinician-rated outcomes.", "results_summary": "Yohimbine was well tolerated and showed faster improvement and better outcomes on self-report measures of social anxiety and depressed mood, but not on clinician-rated measures. The benefits were more pronounced in patients who reported low fear at the end of exposure exercises.", "population_specificity": "Adults with DSM-IV diagnosed social anxiety disorder (n = 40).", "effective_dosage": "10.8 mg yohimbine HCl administered 1 hour before each of four exposure sessions.", "study_duration": "Four exposure sessions, with follow-up measurements at posttreatment and 1-month follow-up.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:51:54.935562+00:00"}
{"study_id": 48770, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether yohimbine, as an anxiogenic drug, would increase hippocampal theta frequency in rats to assess the construct validity of the theta model of anxiety.", "results_summary": "Yohimbine significantly increased behavioral measures of anxiety in the elevated plus-maze but did not increase hippocampal theta frequency, contrasting with the expected neurophysiological response. This discrepancy questions the construct validity of the theta model for anxiety.", "population_specificity": "Urethane-anesthetized rats", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:51:57.228455+00:00"}
{"study_id": 48771, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to develop and validate a high-performance thin-layer chromatographic method for determining yohimbine hydrochloride in pharmaceutical preparations.", "results_summary": "The study successfully developed a sensitive and accurate HPTLC method for quantifying yohimbine hydrochloride, with linear calibration (80-1000 ng/spot, R\u00b2=0.9965) and effective separation from other components. Yohimbine content varied widely in tested preparations (2.3-5.2 mg/tablet in pure alkaloid products vs. 0-1.8 mg/capsule in bark supplements).", "population_specificity": "Pharmaceutical preparations and dietary supplements containing yohimbine or yohimbe bark.", "effective_dosage": "Not applicable (analytical method study).", "study_duration": "Not applicable (analytical method study).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:51:59.256707+00:00"}
{"study_id": 48772, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of yohimbine on cold stress-induced erectile dysfunction in rats, comparing its efficacy with sildenafil.", "results_summary": "Yohimbine significantly improved sexual arousal, potency, and mating behavior in stressed rats but did not alter testosterone, FSH, LH, or cholesterol levels. It also demonstrated a dose-dependent relaxant effect on rat corpus cavernosum strips.", "population_specificity": "Male rats subjected to cold stress-induced erectile dysfunction.", "effective_dosage": "0.2 mg/kg, intraperitoneally, administered daily.", "study_duration": "14 consecutive days.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:00.079091+00:00"}
{"study_id": 48773, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate whether yohimbine could reverse the protective effects of brimonidine on glutamate- and hydrogen peroxide-induced damage in rat-cultured spiral ganglion neurons.", "results_summary": "Yohimbine reversed the protective effects of brimonidine, indicating its role as an antagonist of \u03b1(2)-ARs in this context. The study did not assess yohimbine's standalone effects but demonstrated its interaction with brimonidine.", "population_specificity": "Rat-cultured spiral ganglion neurons (SGNs)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Reversed brimonidine's protective effects", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:00.765482+00:00"}
{"study_id": 48774, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether \u03b12-adrenoceptor inhibition with yohimbine affects islet blood flow and metabolic parameters in GK rats, a model for type 2 diabetes.", "results_summary": "Yohimbine decreased blood glucose and increased serum insulin concentrations in GK rats but had no effect in WF rats. It also reduced islet blood flow in GK rats to levels similar to WF rats, suggesting \u03b12-adrenoceptor overexpression may contribute to increased islet blood flow in diabetes.", "population_specificity": "Anesthetized GK (type 2 diabetic) and Wistar-F (control) rats.", "effective_dosage": "2.5 mg/kg BW, administered intravenously.", "study_duration": "Single-dose intervention (duration not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:01.833660+00:00"}
{"study_id": 48775, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to determine whether yohimbine could overcome the suppressive effects of short winter-like day lengths on male sexual behavior in rodents.", "results_summary": "Yohimbine treatments that increased copulatory behavior in long days were ineffective in facilitating male sexual behavior under short-day conditions, both during gonadal regression and after recrudescence. The study suggests that the brain circuit mediating sexual behavior may be less responsive to yohimbine in short days or that neurotransmitter changes differ between day lengths.", "population_specificity": "Male hamsters exposed to short winter-like day lengths.", "effective_dosage": "Not specified", "study_duration": "16 weeks (gonadal regression) and 32 weeks (gonadal recrudescence) of short-day treatment.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:02.559029+00:00"}
{"study_id": 48777, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to determine whether yohimbine hydrochloride (YOH) enhances the effects of virtual reality exposure therapy (VRET) for fear of flying by increasing noradrenaline levels.", "results_summary": "Both YOH and placebo groups showed significant anxiety reduction after VRET, but YOH did not enhance treatment outcomes despite successfully increasing noradrenaline levels. The study found no evidence that YOH improved efficacy beyond VRET alone.", "population_specificity": "Participants meeting DSM-IV criteria for a specific phobia (fear of flying).", "effective_dosage": "10 mg administered 1 hour prior to exposure sessions.", "study_duration": "4 weekly 1-hour exposure sessions.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:03.410179+00:00"}
{"study_id": 48776, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to determine the pharmacokinetics of yohimbine when administered alone and in combination with detomidine in horses.", "results_summary": "The study found that yohimbine's systemic clearance and volume of distribution decreased when administered after detomidine, leading to higher plasma concentrations. The elimination half-life of yohimbine remained unchanged, but the increased plasma concentrations could potentially cause adverse effects.", "population_specificity": "Nine healthy adult horses aged 9 \u00b1 4 years and weighing 561 \u00b1 56 kg.", "effective_dosage": "0.2 mg kg(-1) yohimbine IV.", "study_duration": "Single-dose administration with a minimum 1-week washout period between regimens.", "interactions": "Detomidine significantly affected yohimbine's pharmacokinetics.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:03.914510+00:00"}
{"study_id": 48778, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate whether yohimbine, an \u03b12A AR antagonist, could reduce the severity of endotoxin-induced acute lung injury in rats by modulating inflammatory responses.", "results_summary": "Yohimbine significantly improved oxygenation, reduced white blood cell counts, lowered lung histopathological scores, and decreased levels of inflammatory cytokines (TNF-\u03b1, IL-1\u03b2, IL-6) compared to the LPS-only group, suggesting it alleviates pulmonary inflammation via \u03b12A AR blockade.", "population_specificity": "Male Sprague-Dawley rats", "effective_dosage": "2 mg/kg, intraperitoneal (single dose)", "study_duration": "Effects assessed at 6, 24, and 48 hours post-administration", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:05.862494+00:00"}
{"study_id": 48780, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the role of delta opioid peptide receptors (DOP-Rs) in yohimbine-stress-induced reinstatement of ethanol-seeking behavior in rats.", "results_summary": "Yohimbine increased ethanol-seeking behavior in rats, an effect mediated by DOP-Rs, as pretreatment with the DOP-R antagonist SoRI-9409 reduced this reinstatement. Yohimbine also increased DOP-R-stimulated GTP\u03b3S binding in brain membranes, which was inhibited by SoRI-9409.", "population_specificity": "Male Long-Evans rats trained to self-administer ethanol.", "effective_dosage": "2 mg/kg, intraperitoneal (i.p.)", "study_duration": "Not specified (daily 30-minute sessions until extinction criteria were met)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:08.233235+00:00"}
{"study_id": 48781, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the effectiveness of yohimbine and pyridostigmine in improving orthostatic hypotension and explore potential synergistic effects when combined.", "results_summary": "Yohimbine significantly improved standing diastolic blood pressure and presyncopal symptoms compared to placebo, while pyridostigmine showed no significant effect. No synergistic effect was observed when the two were combined.", "population_specificity": "31 patients with severe autonomic failure.", "effective_dosage": "5.4 mg of yohimbine.", "study_duration": "Single administration with measurements taken 60 minutes post-dose.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:08.247754+00:00"}
{"study_id": 48782, "supplement_id": 1691, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the efficacy and safety of a combination of yohimbine and L-arginine (SX) in treating mild to moderate erectile dysfunction.", "results_summary": "The study found that SX was significantly more effective than placebo at week 4, with no significant difference in adverse events between the two groups. The conclusion was that SX is safe and effective for short-term treatment of mild to moderate ED.", "population_specificity": "Married males aged 25-50 with mild to moderate erectile dysfunction (IIEF scores 15-25) and a minimum 3-month history of ED.", "effective_dosage": "One capsule on demand (specific dosage not detailed).", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:09.275116+00:00"}
{"study_id": 48784, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare male and female rats on stress-induced relapse of cocaine seeking using yohimbine and examine the potential sex-specific treatment effects of allopregnanolone.", "results_summary": "Female rats were more resistant to extinction and showed greater reinstatement of cocaine seeking after yohimbine injections compared to males. Allopregnanolone blocked yohimbine's effect in females but not males.", "population_specificity": "Male and female rats", "effective_dosage": "2.5 mg/kg yohimbine", "study_duration": "14-day maintenance period, followed by extinction and reinstatement testing", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:10.896975+00:00"}
{"study_id": 48783, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether neuropeptide Y (NPY) could block yohimbine-induced reinstatement of alcohol-seeking behavior, a model of relapse.", "results_summary": "NPY dose-dependently blocked yohimbine-induced reinstatement of alcohol seeking but did not affect ongoing alcohol self-administration. Yohimbine and NPY both activated neuronal populations in stress- and reward-related brain regions, with additive effects.", "population_specificity": "Rats (animal model)", "effective_dosage": "Yohimbine (1.25 mg/kg, intraperitoneal)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:11.009232+00:00"}
{"study_id": 48785, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine how yohimbine, a pharmacological stressor, interacts with heroin-associated cues to influence relapse behavior in an animal model.", "results_summary": "Yohimbine alone and heroin-associated cues alone reliably reinstated heroin-seeking behavior. When yohimbine preceded cue-induced reinstatement, the response was significantly potentiated (3-4x higher than cues or yohimbine alone).", "population_specificity": "Rats in an animal model of heroin relapse.", "effective_dosage": "1.25 or 2.5 mg/kg", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:11.181426+00:00"}
{"study_id": 48786, "supplement_id": 1691, "safety_score": "20", "efficacy_score": null, "quality_score": 60, "study_goal": "The researchers aimed to document severe acute neurotoxic and hemodynamic effects following a large ingestion of yohimbine in a bodybuilder.", "results_summary": "A 37-year-old bodybuilder experienced severe neurotoxic effects (loss of consciousness, seizures, extreme hypertension) after ingesting 5 g of yohimbine, requiring intensive medical intervention. Elevated blood levels of yohimbine were detected, with a mean half-life of 2 hours.", "population_specificity": "37-year-old male bodybuilder", "effective_dosage": "5 g (single ingestion)", "study_duration": "Acute effects observed within 2 hours; monitoring continued for 22 hours", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:11.766567+00:00"}
{"study_id": 48787, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the antagonistic effects of yohimbine and atipamezole on xylazine-induced diuresis in dogs.", "results_summary": "Yohimbine effectively reversed xylazine-induced diuresis, showing greater potency than atipamezole, though its effects were not dose-dependent. Both drugs similarly reversed xylazine-induced changes in urine and plasma parameters without significantly altering hormonal profiles.", "population_specificity": "Five healthy male beagles.", "effective_dosage": "50, 100, or 300 \u00b5g/kg intramuscularly.", "study_duration": "Single administration with measurements over 24 hours.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:15.547116+00:00"}
{"study_id": 48789, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the potency of yohimbine hydrochloride (YH) and MRS2179 in inhibiting collagen-epinephrine interaction in patients with acute coronary syndrome (ACS) receiving dual antiplatelet therapy.", "results_summary": "YH showed greater potency in inhibiting collagen-epinephrine interaction compared to MRS2179, with lower molar concentrations required for blocking the effect. The study suggests alpha2A-adrenoreceptors play a major role in this interaction.", "population_specificity": "Patients with acute coronary syndrome (ACS) receiving aspirin and clopidogrel therapy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:15.794135+00:00"}
{"study_id": 48788, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to characterize the pharmacological effects of Yohimbine on noradrenergic activity in the brain and its potential role in anxiety-related behaviors.", "results_summary": "Systemic administration of Yohimbine increased noradrenergic cell firing in the locus coeruleus and catecholamine release in the amygdala, effects that were blocked by prior administration of clonidine or anxiolytics like chlordiazepoxide and buspirone, suggesting Yohimbine's anxiogenic effects are mediated by alpha-2 adrenoceptors.", "population_specificity": "Anaesthetized rats", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Clonidine, chlordiazepoxide, and buspirone counteract Yohimbine's effects.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:16.332834+00:00"}
{"study_id": 48790, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 40, "quality_score": 75, "study_goal": "The researchers aimed to determine whether yohimbine enhances fear extinction learning in rats and whether this effect persists during drug-free retention tests.", "results_summary": "Yohimbine dose-dependently reduced freezing during extinction training but did not improve retention of extinction learning when tested drug-free. The highest dose reduced bar-press suppression, but effects were not sustained post-treatment.", "population_specificity": "Rats (animal study)", "effective_dosage": "1.0, 2.0, or 5.0 mg/kg (intraperitoneal injection, single dose)", "study_duration": "3 days (conditioning on day 1, extinction training on days 2 and 3)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:18.626491+00:00"}
{"study_id": 48791, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether yohimbine hydrochloride enhances the effectiveness of exposure therapy for claustrophobia in humans.", "results_summary": "Both yohimbine and placebo groups improved post-treatment, but the yohimbine group showed significantly greater reduction in peak fear at one-week follow-up, with large to very large effect sizes across measures.", "population_specificity": "Adults with marked claustrophobic fear (71% undergraduate students, 29% community volunteers).", "effective_dosage": "10.8 mg prior to each exposure session.", "study_duration": "2 one-hour exposure sessions.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:18.960734+00:00"}
{"study_id": 48792, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether repeated exposure to yohimbine during extinction training affects the rate of extinction and subsequent reinstatement of cocaine seeking in rats.", "results_summary": "Rats treated with yohimbine before extinction sessions showed slower extinction and reduced yohimbine-induced reinstatement of cocaine seeking, but footshock-induced reinstatement was unaffected.", "population_specificity": "Rats trained to self-administer cocaine", "effective_dosage": "1.25 mg/kg, intraperitoneal injection", "study_duration": "Five days of extinction training with yohimbine, followed by additional extinction without yohimbine", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:19.017378+00:00"}
{"study_id": 48794, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether the CRF1 receptor antagonist antalarmin could attenuate yohimbine-induced increases in alcohol self-administration and relapse behavior in rats.", "results_summary": "Yohimbine increased alcohol self-administration and reinstated alcohol seeking after extinction, effects that were attenuated by antalarmin. Antalarmin alone had no impact on alcohol self-administration or extinction responding, nor did it affect yohimbine-induced corticosterone release.", "population_specificity": "Alcohol-experienced rats", "effective_dosage": "Yohimbine (1.25 mg/kg), antalarmin (10 or 20 mg/kg)", "study_duration": "Several weeks of training, followed by 13 days of extinction testing", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:20.318632+00:00"}
{"study_id": 48793, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to investigate the role of the alpha(2)-adrenergic receptor (alpha(2)-AR) in extinction of cocaine-conditioned place preference (CPP) and glutamatergic transmission in the BNST, specifically examining the effects of yohimbine.", "results_summary": "Yohimbine impaired cocaine CPP extinction in mice, an effect not replicated by the more selective alpha(2)-AR antagonist atipamezole. Yohimbine also depressed glutamatergic transmission in the BNST, independent of alpha(2A)-ARs.", "population_specificity": "C57BL/6J mice", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:20.738962+00:00"}
{"study_id": 48795, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether Ro60-0175 could reduce cocaine-seeking behavior triggered by yohimbine, a pharmacological stressor, and drug-associated cues.", "results_summary": "Yohimbine (1 mg/kg) reinstated cocaine-seeking behavior in rats, and this effect was dose-dependently reduced by Ro60-0175. The reinstatement was context-specific, occurring only in the original self-administration environment.", "population_specificity": "Rats trained to self-administer cocaine.", "effective_dosage": "1 mg/kg (yohimbine, i.p.)", "study_duration": "Not specified for yohimbine alone; Ro60-0175 effects were tested over 8 days.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:24.420011+00:00"}
{"study_id": 48796, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether yohimbine enhances the antidepressant effects of fluoxetine or venlafaxine in a mouse model of depression.", "results_summary": "Yohimbine potentiated the antidepressant effects of both fluoxetine and venlafaxine, significantly reducing immobility time in the forced swim test compared to either drug alone. The study suggests alpha(2)-receptor involvement in the mechanism of these antidepressants.", "population_specificity": "Male Laca strain mice", "effective_dosage": "2 mg/kg (intraperitoneal)", "study_duration": "Single administration (15 min before antidepressant drugs)", "interactions": "Enhanced effects of fluoxetine and venlafaxine", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:25.113229+00:00"}
{"study_id": 48797, "supplement_id": 1691, "safety_score": "80", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the effectiveness of yohimbine in treating orgasmic dysfunction in men.", "results_summary": "Of the 29 patients, 16 achieved orgasm and ejaculation, with an additional three succeeding with vibrator assistance. Side effects were not severe enough to discontinue treatment, and two patients fathered children post-treatment.", "population_specificity": "Men with orgasmic dysfunction (primary complete, primary incomplete, or secondary).", "effective_dosage": "Initial 20-mg dose, with optional titration at home.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:26.622422+00:00"}
{"study_id": 48798, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine whether yohimbine reverses morphine-induced effects on the hippocampus by activating pleiotrophin/midkine pathways.", "results_summary": "Chronic yohimbine administration increased midkine mRNA levels, and when combined with morphine, it had summatory effects on midkine upregulation, suggesting a role in preventing opioid-induced neuroadaptations. Pleiotrophin expression remained unchanged.", "population_specificity": "Rats (animal study)", "effective_dosage": "Not specified", "study_duration": "Chronic administration (duration not specified)", "interactions": "Interaction with morphine noted", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:28.286322+00:00"}
{"study_id": 48800, "supplement_id": 1691, "safety_score": "30", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to determine the effects of intrathecal yohimbine on locomotion in intact rats, specifically assessing dose-dependent impairment and tachyphylaxis.", "results_summary": "Yohimbine caused dose-dependent hindlimb locomotor impairment, ranging from transient paralysis (200 \u00b5g/20 \u00b5L) to trunk instability (50 \u00b5g/20 \u00b5L). Repetitive high and medium doses led to tachyphylaxis, while low doses did not.", "population_specificity": "Intact rats", "effective_dosage": "50, 100, and 200 \u00b5g/20 \u00b5L, administered every 48 hours", "study_duration": "Multiple injections over an unspecified period (tachyphylaxis observed by the third injection)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:29.018109+00:00"}
{"study_id": 48799, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether noradrenergic (NA) inputs to the bed nucleus of the stria terminalis (BNST) are necessary for Yohimbine's effects on the hypothalamic-pituitary-adrenal (HPA) axis, feeding inhibition, and conditioned flavor avoidance in rats.", "results_summary": "Yohimbine inhibited food intake and supported conditioned flavor avoidance independently of NA inputs to the BNST, but HPA axis activation was significantly blunted in rats with NA input lesions. NA neurons from the medulla provided collateral inputs to the BNST and paraventricular hypothalamus, contributing to Fos expression and HPA activation after Yohimbine treatment.", "population_specificity": "Rats (specifically, those with NA input lesions in the BNST).", "effective_dosage": "5.0 mg/kg, intraperitoneal injection.", "study_duration": "Not specified (terminal experiment conducted 90-120 min post-injection).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:30.360460+00:00"}
{"study_id": 48802, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether yohimbine, an anxiogenic alpha2-noradrenergic receptor antagonist, enhances cocaine-seeking behavior in rats when combined with cocaine-associated cues.", "results_summary": "Yohimbine alone or cues alone reinstated cocaine-seeking behavior (3-4 times extinction levels), but combining yohimbine with cues greatly potentiated responding (10-13 times extinction levels). Plasma corticosterone levels increased during cocaine self-administration but did not correlate with lever-pressing behavior during reinstatement.", "population_specificity": "Rats with a history of cocaine self-administration.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:30.528864+00:00"}
{"study_id": 48801, "supplement_id": 1691, "safety_score": "70", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether yohimbine administration activates autonomic parameters and salivary alpha-amylase (sAA) via adrenergic mechanisms, suggesting sAA as an indirect indicator of central sympathetic system activity.", "results_summary": "Yohimbine significantly increased sAA activity, blood pressure, salivary flow rate, and catecholamine levels compared to placebo, but no significant correlations were found between sAA and catecholamines. The results suggest yohimbine activates both autonomic parameters and sAA via adrenergic mechanisms.", "population_specificity": "13 healthy males aged 20-28 years.", "effective_dosage": "0.4 \u00b5g/kg intravenous injection.", "study_duration": "Not specified (short-term, based on repeated sampling before and after injection).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:30.596857+00:00"}
{"study_id": 48804, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the mechanism by which yohimbine inhibits spontaneous activity of prefrontal neurons in rats, specifically its action through alpha2A/D-receptor subtypes.", "results_summary": "The study found that yohimbine inhibits spontaneous activity of prefrontal neurons via alpha2A/D-receptor mechanisms, an effect mimicked by BRL44408 and blocked by imiloxan, suggesting increased norepinephrine release and postsynaptic inhibition through alpha2B-receptors.", "population_specificity": "Rats (prefrontal neurons)", "effective_dosage": "Microiontophoretic application (specific dosage not provided)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:32.743036+00:00"}
{"study_id": 48803, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the binding affinities and functional subtype selectivities of tethered yohimbine ligands for human alpha(2)-AR subtypes, specifically assessing whether the second pharmacophore is essential for selectivity.", "results_summary": "The study found that tethered yohimbine analogs exhibited higher binding affinities and selectivity for the alpha(2C)-AR subtype compared to alpha(2A)- and alpha(2B)-ARs, with some analogs showing significant fold selectivities. Functional assays confirmed the antagonist activities and selectivity profiles of these compounds.", "population_specificity": "Human alpha(2)-AR subtypes expressed in Chinese hamster ovary cells (in vitro study).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:33.015497+00:00"}
{"study_id": 48805, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether yohimbine, an alpha-2 adrenoceptor antagonist, could induce stress-related relapse to palatable food seeking in rats on a restricted diet.", "results_summary": "Yohimbine injections reliably reinstated food-seeking behavior in rats after extinction, an effect attenuated by the CRF1 receptor antagonist antalarmin, suggesting CRF involvement in stress-induced relapse.", "population_specificity": "Rats on a restricted diet (75-80% of daily standard food).", "effective_dosage": "Not specified", "study_duration": "Single injection (acute administration)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:34.175838+00:00"}
{"study_id": 48807, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether alpha-2 adrenergic activity is involved in the cognitive-enhancing effects of Ginkgo biloba extract by examining yohimbine's impact on prefrontal cognitive function in rats.", "results_summary": "Yohimbine reduced choice accuracy in a delayed alternation task in a dose- and delay-dependent manner. Ginkgo biloba extract prevented this reduction at higher doses (50, 100, or 200 mg/kg), suggesting its cognitive effects may involve alpha-2-adrenoceptors.", "population_specificity": "Male Wistar rats", "effective_dosage": "3 or 4 mg/kg (intraperitoneal)", "study_duration": "Acute administration", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:36.879552+00:00"}
{"study_id": 48806, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to examine the duration of yohimbine's stimulatory effects on ejaculation in male dogs and its interaction with clonidine.", "results_summary": "Yohimbine (0.1 mg/kg) significantly increased ejaculated semen volume and shortened ejaculation onset for up to 5 hours, but effects diminished by 8-24 hours. It also blocked clonidine-induced ejaculatory inhibition when administered 1-5 hours prior.", "population_specificity": "Male dogs", "effective_dosage": "0.1 mg/kg, intraperitoneal", "study_duration": "Effects assessed at 0.5, 1, 3, 5, 8, and 24 hours post-administration", "interactions": "Clonidine (alpha2-adrenoceptor agonist)", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:37.309728+00:00"}
{"study_id": 48808, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to examine whether yohimbine, an alpha(2)-adrenoceptor antagonist, could protect against GFAP alterations caused by chronic morphine treatment.", "results_summary": "Yohimbine pretreatment reduced morphine-induced GFAP upregulation in key brain regions, suggesting it mitigates astroglial reactions linked to chronic morphine exposure. The findings indicate alpha(2)-adrenergic mechanisms may play a role in morphine-induced brain pathology.", "population_specificity": "Rats treated with chronic morphine", "effective_dosage": "2 mg kg(-1), intraperitoneally, 30 min before each morphine injection", "study_duration": "13 days", "interactions": "Morphine (chronic treatment)", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:38.058942+00:00"}
{"study_id": 48809, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether yohimbine antagonizes the antidepressant-like effects of tramadol and desipramine in a mouse model of depression.", "results_summary": "Yohimbine (2 mg/kg, i.p.) antagonized the antidepressant-like effects of both tramadol and desipramine in mice subjected to unpredictable chronic mild stress, suggesting its role in modulating the noradrenergic system.", "population_specificity": "BALB/c mice subjected to unpredictable chronic mild stress.", "effective_dosage": "2 mg/kg, intraperitoneal injection.", "study_duration": "Not specified (treatment duration not detailed in abstract).", "interactions": "Antagonized effects of tramadol and desipramine.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:38.319173+00:00"}
{"study_id": 48810, "supplement_id": 1691, "safety_score": "85", "efficacy_score": 70, "quality_score": 90, "study_goal": "The researchers aimed to assess the pharmacokinetics, pharmacodynamics, and safety of NMI 861 (containing yohimbine and L-arginine) in healthy males, including its interaction with intravenous nitroglycerine (GTN).", "results_summary": "NMI 861 was well tolerated with no significant adverse reactions. It showed a small but significant difference in systolic blood pressure compared to placebo but no significant interaction with GTN-induced hypotension.", "population_specificity": "Healthy male subjects (16 in the first study, 12 in the second).", "effective_dosage": "7.7 mg yohimbine tartrate combined with 6 g L-arginine glutamate (single oral dose).", "study_duration": "Acute administration (single dose).", "interactions": "No significant hypotensive interaction with intravenous GTN detected.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:39.411265+00:00"}
{"study_id": 48813, "supplement_id": 1691, "safety_score": "30", "efficacy_score": 50, "quality_score": 20, "study_goal": "The researchers aimed to describe a paradoxical adverse effect of yohimbine in a patient with CREST syndrome using it for erectile dysfunction.", "results_summary": "The study found that yohimbine worsened Raynaud's phenomenon in a patient with CREST syndrome, despite its intended use for erectile dysfunction. The case highlights a potential contraindication in certain populations.", "population_specificity": "A patient with CREST syndrome (calcinosis, Raynaud's phenomenon, esophageal dysfunction, sclerodactyly, and telangiectasia).", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:41.620802+00:00"}
{"study_id": 48811, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of yohimbine with sildenafil, phentolamine, and L-arginine on rabbit corpus cavernosum smooth muscle relaxation and nitrergic transmission.", "results_summary": "Yohimbine did not show significant effects on electrical field stimulation-induced relaxation of rabbit corpus cavernosum and had a lower potency (ED50 = 35.84 \u00b1 2.24 \u00b5M) compared to sildenafil and phentolamine. It reduced phenylephrine-induced tone but was less effective than other tested drugs.", "population_specificity": "Rabbit corpus cavernosum (in vitro study)", "effective_dosage": "3 x 10^(-7) - 3 x 10^(-5) M", "study_duration": "Not specified (acute in vitro experiment)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:41.847056+00:00"}
{"study_id": 48815, "supplement_id": 1691, "safety_score": "40", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to compare the efficacy and effects of yohimbine versus atipamezole in reversing amitraz intoxication in dogs.", "results_summary": "Yohimbine effectively reversed all amitraz-induced alterations but caused significant cardiorespiratory side effects like tachycardia and tachypnea. Atipamezole was also effective but with fewer cardiorespiratory effects, suggesting it as a potential alternative.", "population_specificity": "Thirty dogs divided into three groups.", "effective_dosage": "0.1 mg/kg yohimbine intravenously.", "study_duration": "Monitored for 360 minutes.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:45.297829+00:00"}
{"study_id": 48814, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to analyze the effects of iontophoretically applied yohimbine on prefrontal cortical neurons in rats to understand its antagonistic and hyperpolarizing effects on presynaptic alpha2 receptors.", "results_summary": "Yohimbine simulated the inhibitory effect of norepinephrine on PFC neurons, acting primarily on presynaptic alpha2 receptors rather than postsynaptic ones. The effect was not blocked by known alpha1 or postsynaptic alpha2 receptor agents, suggesting a specific mechanism of action.", "population_specificity": "Rat prefrontal cortical (PFC) neurons in vivo", "effective_dosage": "Iontophoretically applied (specific dosage not provided)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:45.714030+00:00"}
{"study_id": 48818, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the specificity of regional brain Fos activation in response to cues associated with the anxiogenic drug yohimbine and compare it to activation patterns seen with rewarding drugs.", "results_summary": "Yohimbine elicited a progressively sensitized locomotor response in rats and, upon re-exposure to the paired environment without the drug, conditioned increases in motor activity were observed. Fos expression increased in the basolateral amygdala but remained unchanged in the prefrontal cortex, contrasting with patterns seen with rewarding drugs.", "population_specificity": "Rats", "effective_dosage": "2 mg/kg, intraperitoneally (i.p.), once per day", "study_duration": "10 consecutive days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:47.089250+00:00"}
{"study_id": 48817, "supplement_id": 1691, "safety_score": "75", "efficacy_score": 80, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the effectiveness of Yohimbine hydrochloride in enhancing arterial blood inflow to the penis and its efficacy in treating erectile dysfunction.", "results_summary": "Yohimbine hydrochloride at a single dose of 5-10 mg improved arterial blood inflow to the penis, and a mean daily dose of 15-20 mg was effective in treating erectile dysfunction, with response rates ranging from 38% to 84% depending on the dysfunction type. Occasional side effects were noted but could be managed by dose reduction.", "population_specificity": "153 men with erectile dysfunction (results available for 140).", "effective_dosage": "Single dose of 5-10 mg; mean daily dose of 15-20 mg.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:47.174919+00:00"}
{"study_id": 48819, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine the effects of yohimbine on REM sleep disturbances in clomipramine-induced depressed rats.", "results_summary": "Yohimbine microinjection significantly reduced the total duration and number of REM sleep episodes compared to control saline injections, indicating its potential to attenuate REM sleep disturbances in this model.", "population_specificity": "Clomipramine-induced depressed rats.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:49.021278+00:00"}
{"study_id": 48820, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether combining Yohimbine with L-arginine enhances subjective and physiological sexual arousal in postmenopausal women with Female Sexual Arousal Disorder.", "results_summary": "The combination of L-arginine and Yohimbine significantly increased vaginal pulse amplitude responses at 60 minutes post-administration compared to placebo, though subjective arousal reports did not differ between treatment groups.", "population_specificity": "Postmenopausal women with Female Sexual Arousal Disorder.", "effective_dosage": "6 mg Yohimbine HCl (single dose per session).", "study_duration": "Acute administration (effects measured at 30, 60, and 90 minutes post-dose).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:49.838502+00:00"}
{"study_id": 200633, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the evidence for Yohimbine's efficacy in treating erectile dysfunction based on randomized-controlled trials.", "results_summary": "Yohimbine was among the most common ingredients in ED supplements, but the abstract does not specify its individual efficacy results. Overall, 19% of ingredients received strong positive evidence (A grade), while 68% had contradicting, negative, or lacking evidence (C or D grades).", "population_specificity": "Not specified (general male population seeking ED or testosterone supplements).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:52.907710+00:00"}
{"study_id": 200634, "supplement_id": 1691, "safety_score": "25", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to determine the prevalence and severity of yohimbine-related adverse drug events reported to the California Poison Control System between 2000 and 2006.", "results_summary": "The study found a substantial increase in yohimbine-associated adverse events, primarily involving herbal products, with common effects including gastrointestinal distress, tachycardia, anxiety/agitation, and hypertension. Yohimbine exposures were linked to more severe outcomes and higher healthcare facility management needs compared to average substance exposures.", "population_specificity": "Adults aged 18 and older who were symptomatic after yohimbine exposure.", "effective_dosage": "Not specified", "study_duration": "Retrospective analysis over 7 years (2000-2006)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:53.992733+00:00"}
{"study_id": 45963, "supplement_id": 1692, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effects of zeaxanthin dipalmitate (ZD)-enriched emulsion on gut microbiota and inflammation in a mouse model of colitis.", "results_summary": "Supplementation with ZD-enriched emulsion improved serum indicators, reduced pro-inflammatory cytokines, increased tight junction proteins, and modulated gut microbiota, particularly enriching beneficial genera like Akkermansia and Lactobacillus. The emulsion showed potential health-promoting roles.", "population_specificity": "Mice with dextran sulfate sodium (DSS)-induced colitis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:55.543053+00:00"}
{"study_id": 45962, "supplement_id": 1692, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Zeaxanthin (Zea) combined with exercise (Exc) had therapeutic effects on obesity induced by a high-fat diet (HFD) in rats.", "results_summary": "Zea, Exc, and their combination reduced body weight gain, triacylglycerol, glucose, total cholesterol, and nitric oxide levels while increasing catalase and insulin compared to the HFD group. The combination of Zea and Exc showed better effects than either intervention alone.", "population_specificity": "Male Wistar rats fed a high-fat diet to induce obesity.", "effective_dosage": "Not specified", "study_duration": "5 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:55.965024+00:00"}
{"study_id": 45964, "supplement_id": 1692, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine the effects of zeaxanthin, alone and in combination with brassinolide, on physiological metabolism, chlorophyll fluorescence, and nutritional quality of radish sprouts during cold storage.", "results_summary": "The study found that zeaxanthin combined with brassinolide improved hypocotyl length, fresh weight, secondary metabolites, nutritional content, glutathione levels, PSII photoprotection, and antioxidant capacity in radish sprouts compared to zeaxanthin alone. The combination also outperformed brassinolide alone in enhancing biomass and antioxidant capacity.", "population_specificity": "Radish sprouts stored at 4 \u00b0C.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:57.421500+00:00"}
{"study_id": 45965, "supplement_id": 1692, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether zeaxanthin could attenuate allergic asthma in mice by modulating the p38 MAPK/\u03b2-catenin signaling pathway.", "results_summary": "Zeaxanthin significantly reduced inflammatory markers (IgE, IL-4, IL-5, IL-13, eotaxin), oxidative stress (MDA, SOD, GST, GSH), and collagen deposition in OVA-induced asthma mice, while suppressing the p38 MAPK/\u03b2-catenin pathway.", "population_specificity": "BALB/c nude mice with OVA-induced allergic asthma.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:57.816939+00:00"}
{"study_id": 48816, "supplement_id": 1691, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of the central noradrenergic system in the ejaculatory reflex of rats and evaluate the effects of yohimbine on this reflex.", "results_summary": "Yohimbine enhanced noradrenergic transmission, inducing an ejaculatory genital motor pattern (GMP) without urethral stimulation, which was blocked by clonidine. Clonidine itself induced a GMP via alpha(1)-adrenoceptors, and prazosin attenuated the yohimbine-induced response, suggesting alpha(1)-adrenoceptor involvement.", "population_specificity": "Male sexually experienced Wistar rats subjected to coital reflex exhaustion.", "effective_dosage": "10 microg/animal (single i.v. injection).", "study_duration": "Immediate effects observed post-injection.", "interactions": "Clonidine and prazosin interactions noted.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:52:59.238042+00:00"}
{"study_id": 45967, "supplement_id": 1692, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Zeaxanthin (ZEA) pre-treatment could prevent or defer cognitive defects and neurovascular damage induced by A\u03b21-42 in rats.", "results_summary": "ZEA pre-treatment prevented learning and memory impairment, maintained cerebrovascular ultrastructure, regulated redox state, reduced ET-1 levels, and stabilized A\u03b2 homeostasis by modulating A\u03b2 transport receptors and inflammatory cytokines.", "population_specificity": "Rats (divided into control, A\u03b21-42, ZEA, and ZEA + A\u03b2 groups).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:53:01.528827+00:00"}
